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ABSTRACT 
 
The purpose of this study was to investigate the Isoniazid preventive therapy (IPT) 
initiation amongst eligible HIV positive patients at health facilities in the Polokwane sub-
district to identify key features in the knowledge and practice of health professionals as 
well as available resources at the health facilities. A quantitative non-experimental, 
descriptive, cross-sectional design was used to describe the practice of IPT initiation in 
health facilities. Data were collected using a structured questionnaire with medical 
doctors, operational managers and registered nurses from the district’s 34 health care 
facilities. The census sample was 124. Data were captured and analysed using 
Statistical Package for the Social Sciences (SPSS) Version 24. The results showed that 
the health care professionals knew the policy and procedures for the implementation of 
IPT but lacked knowledge on patient screening. The findings further suggest that record 
keeping and data capturing was not implemented sufficiently. Resources at the facilities 
were found to be sufficient.  
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CHAPTER 1 
 
ORIENTATION TO THE STUDY 
 
1.1 INTRODUCTION 
 
This chapter gives a brief overview of the study. The background of the study, its 
research problem, purpose and objectives, key concepts, research approach and 
design, methodology and layout of the research are described 
 
1.2 BACKGROUND TO THE RESEARCH PROBLEM 
 
The Department of Health in South Africa states that according to the 2013 UNAIDS 
report, an estimated 35.3 million people globally were living with Human 
Immunodeficiency Virus (HIV) in 2012. Sub-Saharan Africa remains the epicentre of the 
epidemic and accounts for nearly 70% of the world burden of HIV and Acquired Immune 
Deficiency Syndrome (AIDS). South Africa is the worst affected country with an 
estimated 6.3 million people living with HIV, which is the largest number of people living 
with HIV and AIDS in the world (South Africa 2015c:1). 
  
From the beginning of the HIV epidemic in South Africa in 1990, the effort to track the 
epidemic has relied mainly on the antenatal sentinel surveillance to monitor the HIV 
prevalence trends at national, provincial and district spheres of government. The 
prevalence of infection gives a snapshot of the magnitude of the disease burden. (South 
Africa 2015c:4). The target sample for the antenatal sentinel survey is the pregnant 
women presenting for their first antenatal visits to public health clinics for the first time in 
their current pregnancy, during October each year (South Africa 2015c:12). The 
purpose of conducting the annual antenatal sentinel HIV point prevalence survey is to 
assess the HIV sero-prevalence amongst first time antenatal clinic attendees. They are 
seen as a particularly suitable “sentinel” group to represent most closely the HIV 
prevalence of the generally sexually active part of the population. It is also used to 
assess trends in HIV prevalence over time (South Africa 2015c:12).    
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The South African National HIV prevalence for 2013 was 29.7%, a slight increase of 
0.2% from the 29.5% in 2012. In the same time, three provinces reported a higher HIV 
prevalence and six provinces a decrease in prevalence (South Africa 2015c:23). 
 
According to the World Health Organization’s (WHO) estimates, South Africa ranks the 
third highest in the world in terms of TB burden (0.4–0.59 million), after India (2.0–2.5 
million) and China (0.9–1.2 million). HIV fuels the TB epidemic with more than 70% of 
TB patients also living with HIV (SANAC 2011:24). 
 
Once infected with TB, the progression to active disease is dependent on the immune 
status of the individual (South Africa 2014:8). In those with normal immunity, 90% will 
not progress and only 10% will develop the active disease. People with suppressed 
immunity are more likely to develop active TB than those with normal immunity; 50–60% 
of HIV positive people infected with TB will go on to develop the active disease. The 
annual risk of TB in an HIV positive person is 10% compared to a lifetime risk of 10% in 
a healthy individual (South Africa 2014:8). 
 
HIV and TB influence each other as infection with HIV increases the risk of progression 
of recent Mycobacterium tuberculosis infection and of reactivation of latent 
Mycobacterium tuberculosis infection by 5–15% annually. HIV also increases the rate of 
relapse and re-infection. HIV infection suppresses the body’s immune system by 
reducing the number of CD4 cells. TB disease can result in the reduction of the CD4 
cells and an increase in viral load thereby accelerating the progression of HIV infection 
to AIDS. Patients with active TB who are HIV-positive have a higher risk of dying from 
TB than those without HIV (South Africa 2014:10).    
 
In South Africa TB preventive therapy is implemented at all public health facilities – 
primary health care clinics, health centres and hospitals – through the administration of 
Isoniazid (INH) medication and is called Isoniazid Preventive Therapy (IPT).  
 
The health system in South Africa is made up of five levels: the national; provincial; 
district; sub-district and health facility levels. The latter refers to hospitals, community 
health centres and primary health care clinics. South African health data flows from the 
health facility level to the sub-district level, from there to the district level and then to the 
province level. From province level it finally moves to the national level, which is the 
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National Department of Health (NDoH). IPT implementation is captured and reported 
through the District Health Information System (DHIS) that collects, captures, stores, 
analyses and reports routine data. 
 
The South African National Strategic Plan (NSP) on HIV, STI and TB 2012–2016 (The 
NSP 2012–2016) estimates that 80% of the South African population is infected with the 
TB bacillus; however, not everyone who is infected will progress to active TB disease. 
Certain populations are at higher risk of TB infection and re-infection, including health 
professionals, miners, prisoners, prison officers and household contacts of confirmed 
TB patients. In addition, certain groups are particularly vulnerable to progressing from 
TB infection to TB disease. These include children, people living with HIV, persons with 
diabetes, smokers, alcohol and substance users, people who are malnourished or have 
silicosis, mobile, migrant and refugee populations and people living and working in 
poorly ventilated environments. These groups are considered ‘key populations’ for TB 
(SANAC 2011:27).    
 
Strategic Objective 2 (SO 2) of the NSP is focused on primary strategies to prevent 
sexual and vertical transmission of HIV and STIs and to prevent TB infection and 
disease, using a combination of prevention approaches (SANAC 2011:39).    
 
Sub-objective 2.6 of SO 2 reads: “Prevent TB infection and disease through intensified 
TB case finding, TB infection control, workplace/occupational health policies on TB and 
HIV, Isoniazid preventive therapy (IPT), immunisation, prevention of multidrug-resistant 
TB (MDR-TB), and reducing TB-related stigma, alcohol consumption and smoking” 
(SANAC 2011:43). 
 
Limpopo Province has established the Provincial Health Information Systems 
Committee (PHIS) to monitor the District Health Management Information System 
(DHMIS) policy implementation and the National Indicator Data Sets (NIDS) collection 
as well as receive reports from provincial health facilities. PHIS Committees ensure that 
all health information systems adhere to national guidelines and specifications (South 
Africa 2011:19).    
 
According to DHIS 2014–2017, Limpopo Province has not reached the target of 90% in 
terms of IPT initiation. Comparing the annual statistics for the financial years 2014/2015 
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to 2016/2017, Limpopo Province achieved 75%, 68% and 75% respectively, while 
Capricorn district reported the lowest during financial year 2015–2016 at 57% and 
Waterberg district the highest at 78%.  
 
In December 2013 the UNAIDS Programme Coordinating Board called on UNAIDS to 
support country- and region-led efforts to establish new targets for HIV treatment scale-
up beyond 2015. The UNAIDS Stakeholders established the following target towards 
ending the AIDS epidemic: by 2020 90% of all people living with HIV will know their HIV 
status, 90% of all people with diagnosed HIV infection will receive sustained 
antiretroviral therapy and 90% of all people receiving antiretroviral therapy will have viral 
suppression (UNAIDS 2014). This is known as the 90-90-90 strategy. The South African 
National Department of Health is supporting the development of 52 costed and 
prioritised district implementation plans that will move South Africa towards achieving 
the 90-90-90 targets for TB and HIV by 2020.  
 
Progress against these targets is closely monitored through a set of cascades, tracer 
indicators, district and facility level targets and dashboards. The district and facility level 
targets are a disaggregation of the national level targets. This is modelled on the highly 
successful approach adopted by South Africa to achieve the Global Plan for elimination 
of Mother-to-Child Transmission (eMTCT) of HIV (South Africa 2015a:1). To achieve the 
90-90-90 targets for TB and HIV by 2020, all health care facilities should initiate 90% 
eligible HIV positive patients on IPT.  
 
1.3 RESEARCH PROBLEM 
 
Continued IPT initiation below the set target of 90% has a negative effect on the 
finances, material resources and human resources of the Limpopo Province and 
ultimately on National level. When IPT initiation is low, patients will ultimately develop 
TB disease; this will lead to more of the available budget, material and human 
resources being channelled to TB treatment so as to cope with the increased number of 
TB patients. It further defeats the NDoH’s initiatives to improve the quality of life of all 
citizens in South Africa. 
 
This research focused on the implementation of the IPT initiation amongst eligible HIV 
positive adult patients at Polokwane, which is the sub-district of the Capricorn district in 
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the Limpopo Province. Polokwane sub-district was selected for the study because 
according to the DHIS 2014–2017 statistics, Polokwane sub-district reported the lowest 
statistics: 64%, 50% and 83% with regards to IPT initiation amongst the five sub-
districts of the Capricorn district (Limpopo 2014–2017). 
 
An investigation of the IPT initiation at Polokwane sub-district is a starting point to 
address the problem of not meeting the National target for IPT in the Polokwane sub-
district. 
 
1.4 THEORETICAL GROUNDING OF THE RESEARCH 
 
A quantitative view is described as being “realist” or sometimes “positivist”. 
 
Realists take the view that research uncovers an existing reality, that the world works 
according to fixed laws of cause and effect and that it is the job of the researcher to use 
objective research methods to uncover that truth. This means that the researcher needs 
to be as detached from the research as possible and use methods that maximise 
objectivity and minimise the involvement of the researcher in the research (Muijs 
2012:3). Quantitative research “[explains] phenomena by collecting numerical data that 
are analysed using mathematically based methods (in particular statistics)” (Brink, Van 
der Walt & Van Rensburg 2012:112). The data produced are always numerical, and 
they are analysed using mathematical and statistical methods (Brink, Van der Walt & 
Van Rensburg 2012:112). 
 
The researcher used the quantitative research approach to investigate the practice of 
IPT initiation in the Polokwane sub-district. The existing reality of IPT initiation amongst 
HIV positive patients was uncovered through the administration of structured 
questionnaires to health professionals responsible for the implementation of IPT. The 
truth about IPT initiation in Polokwane sub-district was out there and needed to be 
uncovered. 
 
1.5 DEFINITION OF TERMS 
 
Isoniazid prevention therapy refers to the administration of Isoniazid (INH), a drug 
used in the fight against tuberculosis, to individuals with latent infection of 
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Mycobacterium tuberculosis in order to prevent progression to active tuberculosis 
disease (South Africa 2010:2). 
 
Initiation refers to the action of beginning something (Oxford Advanced Learner’s 
Dictionary 2015) and in this study it means the action of administering drugs or giving 
the patients the required medication, namely IPT. 
 
Eligible means having the right to do or obtain something (Oxford Advanced Learner’s 
Dictionary 2015). In this study it refers to the rights of individuals diagnosed as HIV 
positive to be initiated on IPT according to the South African National Strategic Plan on 
HIV, STI and TB.   
 
HIV positive individuals refer to those persons whose blood tested reactive to the 
Human Immunodeficiency Virus.  
 
Knowledge refers to facts, information and skills acquired through experience or 
education; the theoretical or practical understanding of a subject (Oxford Advanced 
Learner’s Dictionary 2015). In this study it refers to the facts, information and skills 
acquired by health professionals for dealing with IPT initiation, as found in the official 
guidelines: Guidelines for tuberculosis preventive therapy among HIV infected 
individuals in South Africa. 
 
Practice refers to the actual application or use of an idea, belief or method, as opposed 
to theories relating to it (Oxford Advanced Learner’s Dictionary 2015). In this study it 
refers to the way in which health professionals apply the official guidelines contained in 
Guidelines for tuberculosis preventive therapy among HIV infected individuals in South 
Africa. 
 
1.6 AIM OF THE STUDY 
 
The study investigated the IPT initiation process amongst eligible HIV positive patients 
at health facilities in the Polokwane sub-district to identify key features in the knowledge 
and practice of health professionals as well as available resources at the health 
facilities. 
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1.6.1 Purpose of the study 
 
The findings of this study may be used by the HIV/AIDS, STI and TB (HAST) directorate 
to contribute to the body of knowledge and also be used to increase the IPT initiation to 
meet the national target. 
 
1.6.2 Objectives of the study  
 
The objectives of this study were to determine and describe the 
 
 knowledge of health professionals on the initiation of IPT 
 practice of IPT initiation at the health facilities 
 resources at the health facilities to initiate and capture IPT 
 
1.7 RESEARCH QUESTIONS  
 
Research question 1: Do the facility health professionals (the doctors, operational 
managers and registered nurses) have knowledge on the policy and procedures of IPT 
initiation? 
 
Research question 2: What are the practices of IPT initiation to eligible HIV positive 
patients at the health facility? 
 
Research question 3: What are the available health facility resources to initiate and 
capture IPT? 
 
1.8 RESEARCH DESIGN AND METHOD 
 
Research authors describe a research design as an overarching, procedural plan that 
provides a framework for the methods of selecting respondents, collecting, measuring 
and analysing data adopted by the researcher to answer questions validly, objectively, 
accurately and economically (Kumar 2012:94; Creswell 2014:12; Bryman 2012:46; Gray 
2014:128). This study followed a non-experimental, descriptive, cross-sectional design.  
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The following sections give a brief overview of the research methodology. The detailed 
description of each section is given in chapter 3.  
 
1.8.1 Setting and population of the study 
 
The study setting was the public health facilities in the Polokwane sub-district of the 
Limpopo Province. The sub-district has 34 health facilities, namely one district hospital, 
one community health centre (CHC) and 32 primary health care (PHC) clinics where 
HIV/AIDS services are offered. The health professionals directly involved with the 
HIV/AIDS units in these health facilities were relevant to the study: they were the 
operational managers, registered nurses and medical doctors.  
 
1.8.2 Sample and sampling methods 
 
Kumar (2012:193) defines a sample as a subgroup of the population one is interested in 
and sampling as the process of selecting a few from a bigger group to become the basis 
for estimating the prevalence of an unknown piece of information, situation or outcome 
regarding the bigger group. In this study, however, all the health professionals working 
in the HIV/AIDS units were included. This is known as a census and thus no sampling 
was done (Polit & Beck 2012:324).  
 
1.8.3 Data collection methods and procedures 
 
Polit and Beck (2012:725) describe data collection as the gathering of information 
needed to address a research problem. In this study data was collected using a self-
developed structured questionnaire that investigated the knowledge of the health 
professionals and the practice of IPT at the health facility as well as the availability of 
resources for the initiation of IPT (refer to Annexure G). The researcher took measures 
to ensure that the data collection tool was valid and reliable.  
 
1.8.4 Data management and analysis 
 
Data analysis entails categorising, ordering, manipulating and summarising the data 
and then describing them in meaningful terms (Brink et al 2012:177). Data was captured 
and analysed using the Statistical Package for the Social Sciences (SPSS) Version 24. 
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Percentages and frequencies were used to interpret the data. Chi-square test was used 
to compare groups; the p-values less than 0.05 were considered statistically significant. 
Data analysis was done in consultation with a qualified statistician. 
. 
1.8.5 Ethical considerations  
 
Ethical clearance for the study was obtained from the University of South Africa’s 
Department of Health Studies Research Ethics Committee (refer to Annexure A). 
Permission to conduct the study was obtained from the Limpopo Department of Health, 
at provincial and district levels (refer to Annexure B, C, D and E). A letter to introduce 
the researcher and the study together with approval to conduct the study were given to 
all potential respondents. Written informed consent was obtained from respondents who 
voluntarily took part in the study (refer to Annexure F). 
 
Polit and Beck (2012:150) state that when humans are used as respondents in scientific 
investigations, great care must be exercised in ensuring that the rights of those humans 
are protected. Ethical guidelines seek to work towards protecting the individuals, 
communities and environments involved in the studies against any form of harm, 
manipulation or malpractice (Adams 2013). 
 
The following principles were adhered to in this study: beneficence, respect for human 
dignity, justice, informed consent and researcher integrity. 
 
1.9 SIGNIFICANCE OF THE STUDY 
 
The outcome of the study will be shared with the relevant stakeholders including 
facilities where the study was conducted. The study will contribute to the body of 
knowledge of the HIV/AIDS, STI and TB (HAST) directorate. The findings may be useful 
for the management of the Limpopo Department of Health and to the health 
professionals who seek to solve problems in the IPT initiation. It will thus contribute to 
meeting the target for initiation set by the NDoH. 
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1.10 STRUCTURE OF THE DISSERTATION 
 
Chapter 1 presents an overview of the study. 
 
Chapter 2 discusses the literature review. 
 
Chapter 3 describes the research design and method. 
 
Chapter 4 covers the data analysis, interpretation and results. 
 
Chapter 5 concludes the study, describes its significance and limitations and makes 
recommendations. 
 
1.11 SUMMARY 
 
This chapter described the research problem, aim of the study, defined the key terms 
research design and method, ethical considerations and significance of the study. 
 
Chapter 2 discusses the literature review conducted for the study 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 INTRODUCTION 
 
This chapter describes the literature review that was undertaken for and during the 
study.  
 
Brink et al (2012:70, 71) define literature as the source that is effective in providing the 
in-depth knowledge that the researcher needs to study the elected problem. They 
further provide the following reasons for conducting a literature review: to identify the 
research problem and refine the research question, obtain clues to the methodology 
and instruments, place the study in the context of the general body of knowledge and 
compare the findings of existing studies with those of the study at hand (Brink et al 
2012:70, 71). 
 
Through the assistance of a Unisa librarian, literature was searched using the following 
key words: TB preventive therapy, Isoniazid preventive therapy, HIV infection, 
tuberculosis and TB & HIV. Literature was sourced from Unisa online library, internet, 
journal articles, internal medicine textbooks, various books and the policy guidelines 
released by the South African Department of Health.  
 
Literature indicates that HIV is the strongest risk factor recognised in the reactivation of 
latent tuberculosis infection to active tuberculosis disease (FPD 2015:6). This implies 
that all HIV patients should be screened for TB then initiated on TB treatment or TB 
preventive therapy, depending on the outcome of the TB screening. TB preventive 
therapy and Isoniazid preventive therapy will be used interchangeably throughout this 
study.   
 
2.2 IPT POLICY GUIDELINES IN SOUTH AFRICA 
 
The South African National Department of Health has developed various guidelines to 
give health care professionals guidance on how to manage patients. South Africa`s 
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policy guidelines on IPT initiation recommend TB screening once an individual is 
diagnosed HIV positive then followed by IPT initiation if eligible. Therefore, HIV 
diagnosis is the point of entry for IPT initiation. 
 
2.2.1 TB preventive therapy 
 
According to the WHO (2016:3), South Africa accounted for the largest share (45%) of 
people living with HIV who received TB preventive treatment for latent TB infection in 
2015, followed by Malawi, Mozambique and Kenya. The WHO (2016:1) further 
recommended that access to TB preventive treatment needs to be expanded. TB 
preventive treatment reduces the occurrence of TB infection in HIV patients. 
 
The IPT guidelines (South Africa 2010:2) state that TB is the commonest cause of 
morbidity and mortality amongst HIV-infected persons in South Africa and studies have 
shown that tuberculosis accelerates HIV disease progression. Therefore, preventing 
tuberculosis should be offered as an option to people living with HIV/AIDS. While TB 
preventive therapy may not reduce the incidence of tuberculosis in the community, it 
prevents morbidity and mortality attributable to TB at an individual level (South Africa 
2010:2). The South African HIV and TB guidelines suggest that all HIV positive patients 
be screened for TB, through interview, and that all TB patients be tested for HIV (South 
Africa 2010:2; 2015b:106).  
 
TB screening is defined as a method to intensify TB case finding among HIV positive 
patients. It involves asking questions about TB symptoms to identify TB suspects and to 
find out if the patient may have active TB. TB screening is done routinely by trained lay 
counsellors or health care professionals using the TB screening tool. The counsellors or 
the health care professionals systematically inquire about the presence of signs and 
symptoms of active TB disease. The lay counsellor will refer the patient with signs and 
symptoms of TB to the professional nurses for further investigation (South Africa 
2010:2; 2015b:106) (see Annexure H for a copy of the TB screening tool for adults). 
 
TB preventive therapy is the administration of one or more anti-tuberculosis drugs to 
individuals with latent infection of Mycobacterium tuberculosis in order to prevent 
progression to active TB disease (South Africa 2010:2). In South Africa TB preventive 
therapy is implemented at all public health facilities, namely primary health care clinics, 
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health centres and hospitals, through the administration of the Isoniazid (INH) drug; this 
is referred to as Isoniazid preventive therapy (IPT).  
 
The South African National Department of health recommends that TB preventive 
therapy should only be offered if the following prerequisites have been met: high quality 
voluntary counselling and rapid testing for HIV was available; patients were screened 
for active TB disease before initiation of TB preventive therapy; health care 
professionals are able to follow up and monitor patients monthly to encourage 
adherence, address side effects and exclude active TB disease; the HIV/AIDS 
programme takes responsibility for implementing TB preventive therapy and there is 
strong collaboration between HIV/AIDS and TB programmes (South Africa 2010:3). 
 
Recent studies on IPT were done in Ethiopia. A study conducted in Addis Ababa, Semu, 
Fenta, Medhin and Assefa (2017:[1]) reported that IPT significantly reduced tuberculosis 
incidence by 96.3% compared to IPT non-exposed patients. Assebe, Reda, Wubeneh, 
Lerebo and Lambert (2015:[1]) found that IPT use was associated with 50% reduction in 
new cases of tuberculosis and the probability of developing TB was higher in the non-
IPT group. In another study conducted by Yirdaw, Jerene, Gashu, Edginton, Kumar, 
Letamo, Feleke, Teklu, Zewdu, Weiss and Ruff (2014:[1]) IPT was found to be effective 
in reducing TB incidence, independently and with concomitant ART, under programme 
conditions in resource-limited settings. Implementing the widespread use of IPT has the 
potential to reduce TB rates substantially among HIV-infected individuals, in addition to 
other tuberculosis prevention and control efforts in resource limited settings. These 
studies show that implementing IPT initiation amongst eligible patients reduces the 
incidence of TB. 
 
Systematic reviews on the use of IPT revealed similar findings. Briggs, Emerson, Modi, 
Taylor and Date (2015: [1]) reviewed literature on the evidence for the use of IPT in 
adults living with HIV, published from 1995 to 2013. Eligible articles included data on 
mortality, morbidity or retention in care related to the provision of IPT to adults with HIV 
in low- or middle-income countries. They stated that while there was little evidence to 
demonstrate that IPT reduced mortality in people living with HIV (PLHIV), there was 
substantial evidence that IPT reduced TB incidence. Ayele, Mourik, Debray and Bonten 
(2015:[2]) also reported that IPT use substantially contributes in preventing TB in 
persons with HIV in general and in tuberculin sensitive test (TST) positive individuals in 
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particular. Churchyard, Fielding, Lewis, Coetzee, Corbett, Godfrey-Faussett, Hayes, 
Chaisson, Grant and Thibela Study Team (2014:301) reported the successful use of 
Isoniazid in preventing tuberculosis during treatment. 
 
Mindachew, Deribew, Memiah and Biadgilign (2014:1) conducted a study to assess the 
perceived barriers to the implementation of Isoniazid preventive therapy for people living 
with HIV in resource constrained settings in Addis Ababa, Ethiopia. The study revealed 
lack of patient information, patient empowerment and proper counselling on IPT by the 
health care officials. They recommended provision of training or capacity building and 
awareness creation mechanisms for the health workers. Moolphate, Lawpoolsri, 
Pungrassami, Sanguanwongse, Yamada and Kaewkungwal (2013:60) also cited the 
lack of training for health care workers as resulting in a lack of confidence in providing 
IPT as a barrier to implementation of IPT. In contrast, Tikuye (2013:46) indicated that 
health care workers (71.2%) have demonstrated high level of knowledge in IPT 
initiation. 
 
The above evidence strengthens the need for improved IPT practices and the need for 
this study. Improved IPT practices will make the 90/90/90 strategy achievable and 
reduce TB/HIV related morbidities and mortalities.  
 
2.2.2 Eligibility for TB preventive therapy 
 
The IPT guidelines suggest that all HIV positive people with no signs or symptoms 
suggestive of active TB are eligible for TB preventive therapy (South Africa 2010:4; 
2015b:110).  
 
The South African National Department of health classifies the following populations as 
being at particularly high risk of developing TB and likely to benefit from IPT: miners, 
prisoners, TB contacts, health care workers and children. Patients with signs and 
symptoms suggestive of TB must be investigated for TB. If they are found not to have 
TB (that is, their sputum smear and culture are both negative), they should be 
reassessed in three months and, if no longer symptomatic, should be offered TB 
preventive therapy (South Africa 2010:4). 
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2.2.3 Non-eligibility for TB preventive therapy 
 
The IPT guidelines exclude the following patients from initiated on the TB preventive 
therapy: those with signs and/or symptoms of TB, those with active liver disease or who 
are actively abusing alcohol, those with peripheral neuropathy, patients with history of 
adverse reaction to Isoniazid and people who have completed treatment of MDR or 
XDR-TB (South Africa 2010:5; 2015b:110). 
 
2.2.4 Exclusion of active tuberculosis 
 
The IPT guidelines recommend exclusion of active tuberculosis in every patient prior to 
starting TB preventive therapy. This is critical in order to avoid giving a single anti-
tuberculosis drug to patients with TB disease who require a full treatment regimen 
(South Africa 2010:3; 2015b:110). 
 
Prior to initiation of TB preventive therapy, patients should be screened for signs and 
symptoms of active TB disease that include current cough (24 hours or longer), fever, 
loss of weight and drenching night sweats (South Africa 2010:3; 2015b:106). 
 
All patients with one or more sign or symptom are considered TB suspects and must be 
further investigated for active TB disease as per national TB guidelines. They are not 
eligible for TB preventive therapy until active TB disease has been excluded on the 
basis of sputum smear microscopy and mycobacterial culture (South Africa 2010:3). 
 
2.2.5 IPT and pregnancy 
 
The IPT guidelines indicate that research has shown that HIV positive TB cases cause 
10% of maternal deaths in Africa. Active TB during pregnancy is associated with 
spontaneous abortions and adverse perinatal outcomes (South Africa 2010:4). 
 
The IPT guidelines state that the benefits of TB preventive therapy for eligible pregnant 
women, after exclusion of active tuberculosis disease, outweigh the risks of TB 
preventive therapy. The guidelines further recommend the starting of TB preventive 
therapy at any time during pregnancy and that IPT should be completed if a woman falls 
pregnant while taking IPT (South Africa 2010:4). 
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In their study conducted in India, Kapoor, Gupta and Shah (2016:[1]) indicated that IPT 
given to HIV positive pregnant women is highly cost-effective for TB prevention. 
 
2.2.6 IPT and anti-retroviral therapy (ART) 
 
The IPT guidelines indicate that although ART dramatically reduces the risk of 
developing TB, patients on ART are still at increased risk of developing TB compared to 
HIV-negative people. The IPT guidelines state that the risk of developing TB is highest 
in the first six months after initiating ART, when a patient will develop immune 
reconstitution inflammatory syndrome (IRIS). IRIS occurs in patients with confirmed or 
unconfirmed active TB who were not screened for TB prior to receiving ART. As soon 
as the patient is initiated on ART, the immune system begins to recover but then 
responds to previously acquired opportunistic infection with an overwhelming 
inflammatory response (South Africa 2010:4; 2015b:110; Maartens, Cotton, Wilson, 
Venter, Meyers & Bekker 2012:526). It is therefore critical to ensure regular TB 
screening before initiating ART and more especially during the first six months of ART 
initiation. 
 
The guidelines further state that patients who receive IPT and who are eligible for ART 
should complete their IPT while taking ART. IPT should not be stopped because they 
have started ART (South Africa 2010:4); refer to Figure 2.4. 
 
The IPT guidelines report that IPT is well tolerated in patients on ART; it also indicates 
that retrospective cohort studies indicate additional benefits of providing IPT to patients 
during ART, namely reduced occurrence of IRIS, reduced incidence of developing TB 
and reduced mortality rate due to TB. Once TB has been excluded, IPT can be provided 
to patients during ART (South Africa 2010:4). 
 
Studies show that people living with HIV treated by the IPT plus ART had a lower rate of 
severe illness, lower likelihood of mortality, delayed time to death and low TB incident 
rate when compared to patients treated by ART alone (Edessa & Likisa 2015:[2]; 
Maharaj, Gengiah, Yende-Zuma, Naidoo & Naidoo 2017:542; Danyuttapolchai, 
Kittimunkong, Nateniyom, Painujit, Klinbuayaem, Maipanich, Maokamnerd, Pevzner, 
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Whitehead, Kanphukiew & Monkongdee 2017:[1]; Rangaka, Wilkinson, Boulle, Glynn, 
Fielding, Van Cutsem, Wilkinson, Goliath, Mathee, Goemaere & Maartens 2014:[9].) 
Churchyard et al (2014:339) further suggested that scaling up continuous IPT targeted 
at HIV-positive persons, when used in combination with other treatment and prevention 
strategies, may substantially improve TB control. 
 
It is thus important to investigate the implementation of IPT to ensure the benefits of 
such interventions to the communities in the sub-district.  
 
2.2.7 IPT in patients previously treated for TB 
 
The IPT guidelines states that IPT benefits patients who successfully completed TB 
treatment. Therefore, IPT can be started after successful completion of TB treatment or 
at any time after a previous episode of TB, provided that active TB disease is excluded 
(South Africa 2010:4). 
 
In the study conducted by Hermans, Grant, Chihota, Lewis, Vynnycky, Churchyard and 
Fielding (2016: [1]) on the timing of tuberculosis after IPT, the durability of protection by 
IPT was lost within 6–12 months. This simply means that patients could develop active 
TB 6-12 months after completion of IPT. 
 
2.2.8 Recommended regimen 
 
South Africa has adopted a standardised treatment regimen used by all provinces for 
the prevention of TB in HIV-positive patients (South Africa 2010:5). The standard 
regimen for TB preventive therapy is shown in Table 2.1. 
 
Table 2.1 The standard regimen for TB preventive therapy 
 
Category Dose/kg 
Adults Isoniazid (INH) 5 mg/kg/day (maximum 300 mg per day) 
Children Isoniazid (INH) 10 mg/kg/day (maximum 300 mg per day) 
(South Africa 2010:5) 
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2.2.9 When and how to start TB preventive therapy 
 
In South Africa, information about tuberculosis, including preventive therapy, is made 
available to all people living with HIV/AIDS during their follow-up visits at health 
facilities. The IPT guidelines indicate that experiences from trials and operational 
research have stressed the importance of relevant information for the patients including 
the issue of adherence (South Africa 2010:6). 
 
The IPT guidelines recommend discussion and adequate planning of TB preventive 
therapy by health care professionals to ensure full understanding and adherence by the 
patients. For the health care professional to adequately plan for TB preventive therapy, 
they should know and understand the interpretation of the IPT guidelines. If the IPT 
guidelines are not known or incorrectly interpreted, the implementation will not be 
accurate or effective (South Africa 2010:6). 
 
During post-test counselling following diagnosis of HIV, the patient should be informed 
about the benefits of TB preventive therapy, and should be invited to return to the clinic 
for IPT services. The IPT guidelines discourage immediate initiation of TB preventive 
therapy after informing a patient of his/her HIV status (South Africa 2010:6). 
 
2.2.10 Follow-up visits 
 
During on-going counselling sessions, patients receiving TB preventive therapy are 
informed about HIV, symptoms of active TB, adherence to the treatment and side-
effects of Isoniazid. Patients are screened for TB and checked for side effects at every 
follow up visit. Possible side-effects of IPT are nausea and vomiting, jaundice, dark 
urine, right upper quadrant abdominal pain, convulsions, severe rash, psychosis and 
peripheral neuropathy (South Africa 2010:7; 2015b:110; Maartens et al 2012:241).  
 
Patients starting TB preventive therapy are given a one-month supply at a time. They 
are expected to complete the six months of therapy within a period of nine months. This 
means that they are given nine months to complete the treatment that should ideally be 
completed within six months; this allows for a grace period in case one missed or failed 
to take treatment. The missed period of treatment should be recovered within the 9 
months of starting treatment (South Africa 2010:6). 
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Patients are screened for Tuberculosis at every follow up visit. Patients who are found 
to be symptomatic during TB screening must be investigated according to TB 
guidelines: If TB is confirmed, they should start TB treatment and receive Cotrimoxazole 
prophylaxis. This means IPT will be stopped and the patient will be initiated on TB 
treatment (South Africa 2010:6). 
 
2.2.11 Monitor adherence 
 
The IPT guidelines recommend that, in order to monitor adherence, if the patient 
interrupts therapy, the healthcare professional should inquire about the reasons for 
treatment interruption and should counsel the patient on the importance of adherence. 
Isoniazid may be restarted after the healthcare professional has verified that the patient 
has no symptoms suggestive of active TB disease and that obstacles to adherence 
have been addressed. The healthcare professional should make sure that the six 
months of therapy is taken within a nine-month period. If the patient interrupts TB 
preventive therapy for a second time, the healthcare professional should consider 
stopping the therapy (South Africa 2010:7). 
 
Studies conducted by Yotebieng, Edmonds, Lelo, Wenzi, Ndjibu, Lusiama and Behets 
(2015:2055) and Shayo, Moshiro, Aboud, Bakari and Mugusi (2015: [1]) found that 
patients on ART at IPT initiation were found to be more likely to complete IPT on time. 
However, Makanjuola, Taddese and Booth (2014: [12]) argue that adherence to IPT in 
people living with HIV and AIDS (PLWHA) is influenced by the interactions of multiple 
factors. During adherence counselling the health professionals should advise patients to 
adhere to and complete the course of treatment in order to receive the benefits of IPT. 
 
For health professionals to effectively implement the IPT guidelines, knowledge on HIV 
and TB is essential. HIV testing is the entry point for IPT initiation. Sections 2.3 and 2.4 
briefly discuss HIV and TB respectively 
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2.3 HUMAN IMMUNE VIRUS (HIV) 
 
The Foundation for Professional Development (FPD) (2015:6) states that “in 2014, there 
were 36.9 million people living with HIV worldwide with 2 million who were newly 
infected and that 1.2 million people died with AIDS-related causes.”  
 
HIV is transmitted horizontally via sexual contact and via infected body substances that 
come into contact with mucous membranes, non-intact skin or the bloodstream. HIV is 
transmitted vertically, from mother to child (FPD 2015:12; Maartens et al 2012:11). 
When HIV enters the body, it attaches itself to the cells with CD4 receptors that include 
cells such as CD4 cells of the immune system. HIV paralyses the immune system of an 
individual by attacking the CD4 cells (FPD 2014:37; Maartens et al 2012:21). CD4 count 
serves as a useful indictor of the severity of HIV infection (FPD 2015:78).   
 
Viral load is the amount of virus in the blood stream or the concentration of free virus in 
the blood. Viral load is best used to monitor the ART treatment response (FPD 2015:80; 
South Africa 2015b:55; Maartens et al 2012:48). 
 
2.3.1 HIV prevalence in South Africa 
 
Many countries have introduced HIV surveillance systems based on anonymous 
voluntary or unlinked testing of samples from sentinel populations to determine the 
prevalence rate. South Africa and other African countries are examples that use 
anonymous approaches to determine the country`s HIV prevalence (FPD 2015:6). 
 
The Department of Health of South Africa performs a national HIV sero-prevalence 
survey each year to pregnant women aged 15−49 years of age attending public health 
antenatal clinics. The survey is conducted on pregnant women because they can be 
used to represent the sexually active population. The pregnant women who attend the 
antenatal clinic are requested to participate in the HIV sero-prevalence survey 
anonymously. Blood is drawn from each pregnant woman`s veins into the laboratory 
specimen tubes; these are then sent to a laboratory for HIV and syphilis investigations. 
The findings of the survey are generalised to the entire population. In South Africa the 
survey is conducted annually, during October, with the pregnant women who attend the 
public antenatal clinic for the first time. The survey is conducted in 1 500 clinics, in the 
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52 districts of the nine provinces of South Africa. These data have been crucial in 
describing the progression of the HIV epidemic nationally and by province as well as by 
age category (FPD 2015:10, South Africa 2015c:1). 
 
In the nine provinces of SA, there is fluctuation and significant heterogeneity in HIV 
prevalence trends between districts every year. Currently South Africa uses the 2013 
HIV sero-prevalence survey results that were released in 2015. In 2013 the highest 
provincial HIV prevalence was recorded in KwaZulu-Natal (KZN) which increased from 
37.4% in 2012 to 40.1% in 2013. Other provinces with ‘higher’ HIV prevalence 
estimates compared with 2012 are the Eastern Cape (from 29.1% in 2012 to 31.4% in 
2013), Mpumalanga (increased from 35.6% in 2012 to 37.5% in 2013). These small 
increases fell within the expected sampling variability. The provinces with ‘lower’ HIV 
prevalence estimates were North West (from 29.7% in 2012 to 28.2% in 2013) and Free 
State (which decreased from 32.0% in 2012 to 29.8% in 2013) (South Africa 2015c:23).  
The South African progression of the HIV from 2011 to 2013 is shown in figure 2.1. 
 
 
Figure 2.1 HIV prevalence trends among antenatal women by province,  
South Africa 2011–2013 
(South Africa 2015c:24) 
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2.3.2 HIV Prevalence in Limpopo Province 
 
Limpopo Province, like other provinces, has designated sites where the surveillance is 
conducted. The designated sites are in all five districts of the province. 
  
In Limpopo province, Waterberg district continues to record the highest HIV prevalence, 
although a notable decrease of 3% from 30.3% in 2011 to 27.3% in 2013 was noted. 
Vhembe district has consistently recorded the lowest HIV prevalence, from 14.6.0% in 
2011 to 15.0% in 2013 (South Africa 2015c:55). This implies that a large number of 
people are to be screened for TB and be given IPT if found eligible, e.g. in the Capricorn 
district, 21.1% of the population is expected to be living with HIV and should therefore 
be screened for IPT eligibility (South Africa 2015c:55). 
 
The Limpopo province progression of the HIV from 2011 to 2013 is shown in Figure 2.2. 
 
 
Figure 2.2 HIV prevalence trends among antenatal women by district,  
Limpopo province 2011−2012 
(South Africa 2015c:55) 
 
2.3.3 Diagnosis of HIV 
 
Diagnosis refers to the identification of the nature of an illness or other problem by 
examination of the symptoms (Oxford Advanced Learner’s Dictionary 2015).   
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In South Africa, HIV is diagnosed using three types of tests: the Rapid Blood Test and 
Enzyme Linked Immunosorbent Assay (ELISA) for adults and children above 18 months 
of age; and Polymerase Chain Reaction (PCR) for children below 18 months of age. 
The Rapid Blood Test and the ELISA test detect the presence of antibodies to HIV 
whereas PCR detects the DNA of the virus (South Africa 2016:18). The standard HIV 
blood test used at all South African health facilities is the Rapid Blood Test. The ELISA 
test is a reflex laboratory test used in case of repeat discrepant results (South Africa 
2016:18; FPD 2015:59; Maartens et al 2012:42).  
 
The South African National Department of health has developed the HIV testing 
algorithm to be followed when testing the patient or client for HIV through finger prick. 
The HIV test algorithm is shown in Figure 2.3. 
 
 
 
Figure 2.3 HIV testing algorithm 
(South Africa 2016:18). 
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South Africa has adopted the use of two different Rapid HIV test kits at all public health 
facilities, namely the screening test kit and the confirmatory test kit. These two HIV test 
kits are from two different manufacturers. The confirmatory test kit as the name implies 
is used to confirm the reactive results given by the screening test. When the 
confirmatory test gives different results to the screening test (discrepant results), the 
procedure is repeated. ELISA test is used in case of repeat discrepant results. Failure to 
follow the algorithm will lead to giving the patient inaccurate results, which can end up in 
litigation.  
 
There are HIV Testing Service (HTS) registers where HIV testing data are recorded. 
From the HTS registers HIV testing data are captured on DHIS. It is important to 
capture all health facility data on DHIS for accuracy. 
 
It is important for health professionals to have knowledge on diagnosis and data 
capturing of HIV because this is the entry point for IPT initiation. For a patient to be 
considered eligible or not eligible for IPT, HIV testing should first be offered. 
 
2.4 TUBERCULOSIS (TB) 
 
TB is an infectious disease caused by the bacillus Mycobacterium tuberculosis (M. 
tuberculosis). It typically affects the lungs (pulmonary TB) but can affect other sites as 
well (extra-pulmonary TB). The disease is spread in the air when people who are sick 
with pulmonary TB expel bacteria, for example by coughing (WHO 2015:4; Maartens et 
al 2012:232).  
 
TB diagnosis depends on symptom screening of all patients (including HIV positive 
patients) presenting to the health facility and contacts of people with laboratory 
confirmed pulmonary TB disease. In all South African health facilities, all patients 
attending the public health facilities are screened for TB infection; irrespective of their 
presenting illness, e.g. patients coming for respiratory and non-respiratory ailments are 
all screened for TB infection routinely. All those who have symptoms of TB disease 
must be investigated for TB (South Africa 2014:12; Maartens et al 2012:232). 
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2.4.1 Pulmonary TB 
 
Pulmonary TB (PTB) refers to the disease that involves the lung. The main symptoms of 
pulmonary tuberculosis are persistent cough for two weeks or more, or any duration if 
HIV positive; fever for more than two weeks; drenching night sweats and unexplained 
weight loss of more than 1.5 kg in a month (South Africa 2014:12; WHO 2015:4; 
Maartens et al 2012:232). 
 
According to the South African TB guideline, a productive cough, often accompanied by 
systemic symptoms such as fever, night sweats or loss of weight is the commonest 
presentation of pulmonary tuberculosis. Every patient with a positive symptom screen 
must be investigated appropriately. Not all those with TB will have a cough; therefore, a 
high index of suspicion is required, particularly in people who are HIV positive who may 
only have one of the above symptoms. A history of contact with a person with PTB 
increases the likelihood of a TB diagnosis (South Africa 2014:12). 
 
Some patients may present with chest pains due to muscle strain; breathlessness due 
to extensive lung disease or concomitant pleural effusion; localised wheeze due to local 
tuberculous bronchitis, or because of external pressure on the bronchus by an enlarged 
lymph node (South Africa 2014:12). 
 
2.4.2 Diagnosis of TB 
 
The diagnosis of TB depends on numerous factors, namely self-presentation of persons 
with TB symptoms to a health care facility, high index of TB suspicion among health 
care professionals, TB screening practices in health facilities and the capacity to trace 
people with positive results and start them on treatment (South Africa 2014:19). 
 
The South African National Department of Health recommends that all patients 
diagnosed with TB should be started on TB treatment within 2−5 days after confirmation 
of TB disease (South Africa 2014:27). 
 
It is important for health professionals to have knowledge on signs and symptoms 
suggestive of TB diagnosis. This knowledge will enable them to effectively screen and 
exclude TB prior to initiating patients on IPT.   
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2.5 TB/HIV CO-INFECTION 
 
According to the South African TB guideline, infection with HIV increases the risk of 
progression of recent M. tuberculosis infection and of reactivation of latent M. 
tuberculosis infection by 5–15% annually (South Africa 2014:10). The guideline further 
states that HIV also increases the rate of relapse and re-infection. HIV is responsible for 
a large increase in the proportion of patients with smear-negative pulmonary and extra-
pulmonary TB. These patients have lower treatment outcomes, including excessive 
early deaths. Therefore rapid diagnoses of not only smear positive pulmonary TB (PTB) 
but smear-negative pulmonary and extra-pulmonary TB and early initiation of treatment 
is vital to reduction of TB deaths in people living with HIV (South Africa 2014:10). 
 
HIV infection suppresses the body’s immune system by reducing the number of CD4-T 
cells. This in turn results in the loss of the body’s ability to fight the TB infection. Quick 
progression from initial infection to TB disease may also occur in patients with lowered 
immune system. TB disease can result in the reduction of the CD4 cells and increase in 
viral load thereby accelerating the progression of HIV infection to AIDS. Patients with 
active TB who are HIV-positive have a higher risk of dying from TB than those without 
HIV (South Africa 2014:10). 
 
The National Department of Health (South Africa 2014:18) states that tuberculosis and 
HIV/AIDS are the drivers of morbidity and mortality in the country. Therefore, more effort 
must be put into strategies that help to reduce transmission of infection in the 
communities, diagnose Drug Sensitive-TB (DS-TB) and Drug Resistant-TB (DR-TB), 
initiate treatment in all patients diagnosed with TB, retain patients in treatment and care 
until completion of treatment, and prevent TB in people living with HIV by initiating all 
eligible HIV positive people on ART and Isoniazid preventive therapy. 
 
The National Department of Health (South Africa 2016:16) states that HIV testing 
services (HTS) must integrate screening for TB symptoms, STIs and non-communicable 
diseases (NCDs) into the pre-test information session at health facilities and in 
community settings. The HIV and TB screening algorithm is shown in Figure 2.4. 
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Figure 2.4 HIV/TB screening algorithm to increase TB case finding in HTS 
(South Africa 2016:16) 
 
A patient who visits a public health facility for consultation is offered HTS. Pre-test 
counselling is conducted and written consent to perform HIV testing is obtained by the 
health professional before the testing is performed. TB, STI and NCD (Hypertension 
and diabetes) screening are conducted using the department of health screening tools. 
The patient who tested HIV positive is initiated on IPT in the absence of active TB 
disease or TB treatment if active TB is diagnosed. The patient who tests HIV negative is 
initiated on TB treatment if active TB disease is diagnosed or provided with post-test 
counselling in the absence of active TB disease. It is of paramount importance that the 
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health professionals are knowledgeable of TB preventive therapy and effectively 
implements the IPT guideline. 
 
In public health facilities and other high volume HTS settings, pre-test information and 
education sessions may be conducted in a group rather than individually. In settings 
with low HTS volumes individual pre-test counselling sessions may be conducted. 
Information sessions and print materials should be available in the local language of all 
clients who are considering taking the HIV test (South Africa 2016:17). 
 
2.6 IPT IN LIMPOPO PROVINCE 
 
According to DHIS 2014–2017, Limpopo Province has not reached the target of 90% in 
terms of IPT initiation. Comparing the annual statistics for the financial years 2014/2015, 
2015/2016 and 2016/2017, Limpopo Province achieved 75%, 68% and 75% 
respectively, with the Capricorn district reporting the lowest during financial year 
2015/2016 at 57%, and Waterberg district reporting the highest at 78%. There is thus a 
fluctuation in IPT initiation in Limpopo Province and its districts between 2014 and 2017 
(Limpopo DHIS 2014–2017 statistics). Figure 2.5 shows the 2014–2017 IPT initiation 
rates in Limpopo Province per district: 
 
 
Figure 2.5 Limpopo Province IPT initiation rate by districts 
(Limpopo DHIS 2014-2017) 
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None of the districts in Limpopo province achieved the 90% target from 2014 to 2017, 
which poses a concern for the HIV/TB programme. This simply implies that the province 
is not doing well in terms of preventing the occurrence of active TB in HIV positive 
patients. 
 
Figure 2.6 shows the 2014-2017 IPT initiation rates in Capricorn per sub-district: 
 
 
Figure 2.6 Capricorn district IPT initiation rate by sub-districts 
(Limpopo DHIS 2014–2017) 
 
Based on the IPT initiation, Figure 2.5 above, the Polokwane sub-district performed far 
below the district performance.  
 
The Polokwane sub-district reported the lowest IPT initiation according to DHIS 
information for the 2014 to 2017 financial years compared to other sub-districts in 
Capricorn. The low IPT initiation in Polokwane sub-district could be attributed to the lack 
of health professionals’ knowledge on IPT initiation, the IPT implementation process or 
unavailability of resources required for IPT initiation.  
 
In South Africa it is expected that in all public health facilities, patient IPT information be 
recorded in the facility records (IPT register), in patient’s files and also electronically in a 
computer. Some of the health facilities have moved from manual recording of patients’ 
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information on the IPT register to a computer; this simply means that IPT information is 
only recorded in the patient’s file and on computers. There are two types of computer 
systems that are used to capture HIV and TB information, including IPT. These systems 
are the Electronic HIV & AIDS register (TIER.net) and Electronic TB register (ETR.net). 
Data from both TIER.net and ETR.net are important to give a complete analysis and 
complete statistics on HIV and TB. TIER.net captures HIV patients screened for TB and 
those initiated on IPT while ETR.net captures TB patients who are screened for HIV. 
HIV patients who are TB diagnosed will not be initiated on IPT; therefore, they are 
captured on both TIER.net and ETR.net. 
 
It is the responsibility of the professional nurses to ensure that information from facilities 
is recorded and accurately captured on TIER.net and ETR.net for statistical purposes 
and planning effective programmes. 
 
2.7 SUMMARY 
 
This chapter discussed the literature review undertaken for the study. The literature 
covered the IPT policy guideline in South Africa; HIV prevalence in South Africa and 
Limpopo and HIV diagnosis; pulmonary tuberculosis and TB diagnosis; TB/HIV co-
infection; and IPT in Limpopo province. 
 
Chapter 3 describes the research design and methodology. 
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CHAPTER 3 
 
RESEARCH DESIGN AND METHOD 
 
3.1 INTRODUCTION 
 
This chapter describes the methods and procedures that were applied to obtain the data 
required for the study. It discusses the research design, the population, sampling 
method and sample, data-collection instrument, pretesting of data collection instrument, 
data collection, data analysis and ethical considerations. 
 
3.2 RESEARCH DESIGN 
 
Research design refers to the set of logical steps taken by the researcher to answer the 
research question (Brink et al 2012:96). Brink et al (2012:96) further state that the 
research design forms the blueprint of the study and determines the methodology used 
by the researcher to obtain information, such as respondents, elements and unit of 
analysis; to collect and analyse data; and to interpret the results. Polit and Beck 
(2012:741) define research design as the overall plan for addressing a research 
question, including specifications for enhancing the study`s integrity. 
 
This study followed a non-experimental, descriptive cross-sectional design. A non-
experimental design entails no manipulation of the independent variable and, therefore, 
no intervention; nor is the setting controlled. The study is carried out in a natural setting 
and phenomena were observed as they occurred (Brink et al 2012:112; Polit & Beck 
2012:735). 
 
Polit and Beck (2012:725) describe descriptive research as research that typically has 
as its main objective the accurate portrayal of people`s characteristics or circumstances 
and/or the frequency with which certain phenomena occur. According to Brink et al 
(2012:112), descriptive designs may be used to develop theories, to identify problems 
with current practice, to justify current practice, to make judgements or determine what 
other professionals in similar situations are doing.  
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Cross-sectional studies are used to examine data at one point in time, that is, the data 
are collected on only one occasion from different participants, rather than from the same 
participants at several points in time (Brink et al 2012:115; Polit & Beck 2012:725). 
 
This study is non-experimental, descriptive and cross-sectional in nature because the 
researcher intended to describe the practice of IPT initiation in health facilities in 
Polokwane sub-district as it occurred, without manipulation, at one point of time. Data 
were collected during March and April 2018. 
 
3.3 RESEARCH METHOD 
 
Polit and Beck (2012:741) describe the research methods as the techniques used to 
structure a study, gather and analyse information in a systematic fashion. Brink et al 
(2012:199) state that research methodology informs the reader of how the investigation 
was carried out, in other words, what the researcher did to solve the research problem 
or to answer the research question. 
 
3.3.1 Setting and Population 
 
Capricorn district has five sub-districts or local municipalities: Blouberg, Molemole, 
Aganang, Polokwane and Lepelle-Nkumpi. The district has hundred and two (102) 
health care facilities, all the health care facilities provide HIV & AIDS and TB services. 
Brink et al (2012:131) and Flick (2011:71) describe a population as the entire group of 
persons or objects that are of interest to the researcher; in other words, they are the 
people or things that meet the criteria that the researcher is interested in studying. The 
entire set of elements about which the researcher would like to make generalisations is 
called the “target population”. In this study the target population refers to the health care 
professionals (operational managers, registered/professional nurses and doctors) 
working at the HIV/AIDS units in the Capricorn district. A map of Capricorn is shown in 
Figure 3.1. 
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Figure 3.1 Local Municipalities in Capricorn District Municipality 
(CDM Spatial Development Framework 2007) 
 
The accessible population for this study was the health care professionals, namely 
operational managers, registered nurses and doctors working at the 34 HIV/AIDS units 
of the Polokwane sub-district. These health care professionals were selected because 
they are directly responsible for the initiation and capturing of IPT. Operational 
managers, registered nurses and doctors are all responsible for initiating IPT among 
patients; in other words, they prescribe the medication and do follow-ups with the 
patients. The operational managers and registered nurses are also responsible for 
ensuring the availability of stock at the health facilities and capturing the data of IPT 
initiation in the facility records and eventually in the DHIS reports. 
 
Each primary health care clinic has at least two to eight registered nurses, one of whom, 
depending on their workload, is the operational manager of the primary health clinic, but 
there are no doctors. The hospital and Community Health Centre (CHC) have one to 
two registered nurses and one to three doctors.  
 
3.3.2 Sampling and sample size 
 
The sample for this study was all the health care professionals that work in the 
HIV/AIDS units of the Polokwane sub-district; a census was conducted. All the 
operational managers, registered nurses and doctors of the 34 public health facilities 
who were at work during questionnaire distribution, were asked to participate; they 
totalled 139. The breakdown of the sample is as follows: 
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 Thirty-two PHC clinics, each with two to eight registered nurses, including 
operational manager = 130; no doctors 
 One district hospital with two registered nurses and three doctors = five 
 One CHC with three registered nurses and one doctor = four  
 In total, 34 health facilities with a total of 139 health care professionals included 
 
From the 139 health care professionals who were included in this study, only 124 
completed and returned the questionnaire. 
 
3.3.3 Sampling method 
 
Polit and Beck (2012:742) and Brink et al (2012:132) describe sampling as the process 
of selecting a portion of the population in order to obtain information regarding a 
phenomenon in a way that represents the population of interest. In this study all health 
care professionals from all 34 health facilities in the Polokwane sub-district who were at 
work during questionnaire distribution were requested to participate in the study, thus no 
sampling was done; instead a census was conducted.  
 
The final sample for this study consisted of 139 health professionals, namely four 
doctors, 34 operational managers and 101 registered nurses. 
 
3.3.4 Ethical issues related to sampling 
 
 Sampling error 
 
Brink et al (2012:133) and Polit and Beck (2012:742) describe sampling error as the 
difference between a sample statistic and a population parameter. They further state 
that a large sampling error indicates that the sample fails to provide a precise picture of 
the population. 
 
To avoid sampling error, the researcher recruited all health professionals that work at 
the HIV/AIDS units of all health facilities in the Polokwane sub-district.  
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 Sampling bias 
 
Polit and Beck (2012:742) describe sampling bias as distortions that arise when a 
sample is not representative of the population from which it is drawn. Brink et al 
(2012:133) state that sampling bias occurs when samples are not carefully selected. In 
this study there was no sample selection; all health professionals who met the inclusion 
criteria were requested to participate in the study. 
 
The inclusion criteria for respondents were that they: 
 
 work in the health facilities with HIV/AIDS units in the Polokwane sub-district; 
 are health professionals, namely operational managers, registered nurses or 
doctors; 
 are involved in the IPT initiation of eligible patients. 
The duration of work at the unit in years was not used as criteria for inclusion in this 
study because health care professionals are rotated from one unit to the other and 
others are transferred from one institution to the other, this movement does not have an 
impact on the health care professional`s IPT initiation experience.    
 
3.3.4 Data collection 
 
Polit and Beck (2012:725) and Brink et al (2012:147) describe data collection as the 
gathering of information needed to address a research problem. 
 
The researcher used a structured data collection method. To establish a standard for 
competent IPT practitioners, the researcher consulted with operational managers of 
three PHC clinics at the Aganang sub-district and three doctors from the two tertiary 
hospitals. The consensus was that show competence in rendering the service, 
respondents were expected to answer at least seventy five percent (75%) of the 
knowledge questions correctly. The reason for setting the bar at 75%, which means 
passing with distinction, was that IPT initiation is a health issue that can result in 
mortality if not initiated with eligible patients. As such, health care professionals are 
expected to provide quality service delivery to patients.  Put differently, average 
knowledge could result in compromised service delivery and this would pose a risk to 
the lives of the patients.  
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3.3.4.1 Development and testing of the data collection instrument 
 
 Development of data collection instrument 
 
The researcher developed the data collection instrument after studying literature 
relevant to the study topic and objectives (refer to Annexure G). The data collection 
instrument was sent to the statistician for scrutiny before it was submitted to the 
supervisor and the scientific review committee in the Department of Health Studies at 
UNISA for comment. The terms “registered nurse” and “professional nurse” are used 
interchangeably in the field of nursing. The South African Nursing Council uses the term 
“registered nurse” whereas at health care facility level, health care professionals use the 
term “professional nurse”. To match the terminology used at the health care facilities, 
the researcher used the term “professional nurse” in the questionnaire.  
 
 Testing of the data collection instrument 
 
Prior to data collection, the data collection instrument was pre-tested. The purpose of 
the pre-test was to investigate for possible flaws in the instrument, such as ambiguous 
instructions and wording as well as inadequate time limits (Brink et al 2012:175). The 
data collection instrument was pre-tested with respondents that met the inclusion 
criteria but were not part of the sample.  
 
Pre-testing of the questionnaire took place at the Aganang sub-district of the Capricorn 
district. Here two operational managers and six professional nurses from primary health 
care clinics were requested to complete the questionnaire. The feedback given from the 
questionnaire pilot was that the tool is simple and understandable. However, there was 
an indication that patients’ facility files are used to record IPT information. The 
researcher therefore added the question on recording IPT initiation in patients’ file to the 
questionnaire (refer to Annexure G: C5 and E5).  
 
 Validity of the questionnaire 
 
According to Brink et al (2012:218), Joubert, Ehrlich, Katzenellenbogen and Karim 
(2012:117) as well as Polit and Beck (2012:745), validity refers to the extent to which a 
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measurement instrument actually measures what it is meant to measure. The definition 
of validity has two aspects: that the instrument actually measures the concept in 
question and that the concept is measured accurately.  
 
To guarantee validity, the researcher ensured that the questions were short and clear 
and provided adequate coverage of the topic under study by doing a literature review, 
which in this case included all relevant official health policies and programmes. The 
researcher further asked experts in the practice field in the Provincial Department of 
Health of Limpopo Province to check the content and judge how well or accurately the 
questions represented the concepts of the study. She finally selected the appropriate 
sample: those respondents who were indeed involved in the initiation of IPT.  
 
 Reliability 
 
Reliability is the degree of consistency with which an instrument measures the attribute 
it is supposed to be measuring. Reliability of the instrument can be equated with the 
stability, consistency and dependability of a measuring tool (Polit & Beck 2012:331; 
Brink et al 2012:216). 
 
Reliability of the questionnaire in this study was ensured by involving the statistician in 
the development of the questionnaire; by ensuring consistent administration of the 
questionnaire to all respondents; by ensuring that questions were carefully formulated to 
avoid ambiguities, negative questions or double-barrelled questions; and by pre-testing 
the data collection instrument.  
 
3.3.4.2 Characteristics of the data collection instrument 
 
The data collection instrument was structured into the following five sections: 
 
Section A: This section contained the demographic profile, including level of education, 
employment category, period worked and training received. It also asked participants 
how long they had been providing HIV/AIDS and TB services. 
 
  
38 
Section B: This section tested respondents’ knowledge of IPT initiation; questions were 
based on the National Department of Health’s guidelines for Tuberculosis Preventive 
Therapy among HIV infected individuals (South Africa 2010).  
Section C: This section contained questions on the practice of IPT initiation, including 
the process followed before and after IPT initiation. 
 
Section D: This section contained questions on the available resources to initiate IPT at 
the health clinic. 
 
Section E: This section contained general challenges experienced with IPT initiation.  
 
3.3.4.3 Data collection process 
 
After permission for the study was granted by the Limpopo Provincial Department of 
Health and the Capricorn district (refer to Annexure C and Annexure E), an information 
letter, explaining the study was circulated to the potential respondents (refer to 
Annexure F). The researcher obtained informed consent and distributed the 
questionnaires to respondents during the monthly sub-district primary health care 
meeting (refer to Annexure F and Annexure G). The reason for choosing the sub-district 
meeting as the point of distribution was that all the operational managers from the 34 
health care facilities are usually represented at this meeting. The researcher was 
available throughout to provide clarity if questions were raised and to collect the 
questionnaire as it was completed. The researcher personally delivered the 
questionnaires to the remaining operational managers, registered nurses and doctors 
who did not attend the meeting. They were requested to complete them during tea or 
lunch breaks so as not to disturb the operations at the health care facility. The 
researcher collected completed questionnaires and checked for completeness before 
proceeding with data analyses.  
 
3.3.4.4 Data Management 
 
Data will be in safe keeping and will not be available for any purposes other than this 
research. The researcher will ensure that data storage and disposal adhere to the 
values and principles expressed in the UNISA Policy on Research Ethics.   
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3.3.5 Data analysis 
 
Polit and Beck (2012:725) describe data analysis as the systematic organisation and 
synthesis of research data. Data analysis entails categorising, ordering, manipulating 
and summarising the data, and describing them in meaningful terms (Brink et al 
2012:177). 
 
Data was captured and analysed using the Statistical Package for the Social Sciences 
(SPSS) Version 24. Percentages and frequencies were used to interpret the data. The 
Chi-square test was used to compare groups and the p-values less than 0.05 were 
considered statistically significant. Data analysis was done in consultation with a 
qualified statistician. 
 
The option of “certificate” in question A1 (level of education) should not have been 
included because the target population did not include people with a certificate 
qualification. When the researcher checked for completeness of the questionnaire, an 
error was realised; she then sought clarity from the respondents (professional nurses) 
about their qualifications. Although the analysis of this particular question is not 100% 
correct, the fact that the relevant respondents are professional nurses means the 
remaining answers are indeed provided by a professional nurse with a diploma 
qualification. This means there was no negative impact on the information provided 
through the rest of the questions.  
 
Data for knowledge on IPT initiation, practice of IPT initiation and resource availability 
were analysed separately; therefore, no link or correlation was determined.  
 
Data for knowledge on IPT initiation responses were measured as a scale variable 
using scores based on the correctness of responses to the researcher’s conceptual 
knowledge of the IPT policy guidelines. Descriptive statistics of overall knowledge and 
knowledge stratified by demographic characteristics (employment category, educational 
level, years of service in facility, years of service in providing HIV/AIDS services, 
training on TB/HIV collaborative activities and IPT initiation) using measures of 
dispersion (mean, standard deviation, skew, kurtosis and median) were employed.  
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Data for IPT initiation practice responses were categorised as collected and descriptive 
frequency tables for each question were employed.  
 
Description of resource availability is categorical and hence nominal in terms of 
measurement scales. Frequency tables were used to depict the relative availability of 
resources.  
 
3.4 INTERNAL AND EXTERNAL VALIDITY OF THE STUDY 
 
3.4.1 Internal validity 
 
Brink et al (2012:109) and Polit and Beck (2012:157) refer to internal validity as the 
degree to which the outcome of an experiment can be attributed to the manipulated, 
independent variable rather than to controlled irrelevant factors. The researcher 
ensured that the outcome of the study represent a true reflection of reality by not 
exerting influence on the respondents and by including all potential respondents who 
met inclusion criteria. 
 
3.4.2 External validity 
 
Brink et al (2012:111) define external validity as the degree to which the results of a 
study can be generalised to other people and other settings. In this study external 
validity was enhanced because all the health care facilities in the Polokwane sub-district 
were included in the study; therefore, the findings of the study can be generalised to the 
whole sub-district. 
 
3.5 Ethical considerations  
 
Polit and Beck (2012:727) describe ethics as a system of moral values that is 
concerned with the degree to which research procedures adhere to professional, legal 
and social obligations to the study participants. Brink et al (2012:32) state that the 
researcher is responsible for conducting research in an ethical manner from the 
conceptualisation and planning phases, through the implementation phase, to the 
dissemination phase. The researcher adhered to the following ethical principles: 
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 Protection of the rights of the institution 
 
Permission to conduct research was obtained from the Limpopo Department of Health 
and the Capricorn district (refer to Annexure C and Annexure E respectively). 
Information from all health care facilities was kept confidential and no information was 
used against a particular institution or respondents. Respondents completed the 
questionnaires during break times to avoid interfering with service delivery. 
 
 Beneficence 
 
Beneficence refers to the obligation on the part of the investigator to maximise benefits 
for the individual respondents and/or society, while minimising risk of harm to the 
individual (Adams 2013). Brink et al (2012:35) state that to adhere to this principle, the 
researcher needs to secure the well-being of the participant, who has a right to 
protection from discomfort and harm, be it physical, psychological, emotional, spiritual, 
economic, social or legal.  
 
The researcher ensured that the respondents were not subjected to any harm. The 
researcher explained to the respondents that they could terminate their participation at 
any stage without any punishment and that all the information would be kept confidential 
and never be used against them. All respondents were identified by a number for 
anonymity so that no information could be traced back to the respondent. Furthermore, 
the researcher’s purpose with the study was to increase the IPT initiation to meet the 
national target, thus maximising benefits to the citizens of the sub-district. 
 
 Respect for human dignity 
 
The principle of respect for human dignity includes the right to self-determination and 
the right to full disclosure. 
 
 The right to self-determination 
 
Humans should be treated as autonomous agents, capable of controlling their own 
activities and destinies. The principle of self-determination means that respondents 
have the right to voluntarily decide whether or not to participate in a study, without the 
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risk of incurring any penalties or prejudicial preference. It also means that respondents 
have the right to terminate their participation, to refuse to give information or to ask for 
clarity about the purpose of the study (Polit & Beck 2012:154; Brink et al 2012:35). 
 
The researcher informed the respondents of their right to participate voluntarily in the 
study, to ask clarity about the study and to terminate their participation; this was 
indicated on the consent form.  
 
 The right to full disclosure 
 
Full disclosure means that the researcher has fully described the nature of the study, 
the respondents’ right to refuse participation, the researcher`s responsibility as well as 
the likely risks and benefits that could be incurred (Polit & Beck 2012:154; Brink et al 
2012:35). 
 
The study posed no physical risks to participants. However, there was the possibility 
that staff may feel intimidated and worry that the researcher may report them as 
incompetent. The participants were assured on the consent form that both participants 
and their health facility would remain anonymous in the study and that the completed 
questionnaire would be in the researcher’s safe keeping and would not be made 
available for any purposes other than this study. 
 
Even though all health professionals were invited to participate, they could still choose if 
they wanted to participate or not. 
 
 Justice 
 
Individual respondents may withdraw at any time during the study if there is reason to 
suspect that continuation would result in harm or undue distress to them (Polit & Beck 
2012:155; Brink et al 2012:35). 
 
The respondents were assured that neither their participation nor the information they 
might provide to the researcher would be used against them in any way. The principle of 
justice includes the right to fair treatment and the right to privacy. 
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 The right to fair treatment 
 
Respondents have the right to fair and equitable treatment both before and after their 
participation in the study. Fair treatment includes the fair and non-discriminatory 
selection of respondents such that any risks and benefits are equitably shared (Polit & 
Beck 2012:155; Brink et al 2012:36). 
  
Respondents’ selection was based on contribution in initiation and capturing of IPT and 
not on convenience or compromised position of certain types of people. 
 
 The right to privacy 
 
Respondents have the right to expect that any information collected during the course of 
the study will be kept in strictest confidence. This should occur through anonymity and 
confidentiality procedures (Polit & Beck 2012:156; Brink et al 2012:35). 
 
Anonymity was ensured by not writing names on the questionnaire to avoid 
identification of respondents. Respondents were ensured that information they shared 
would be kept confidential and only reported on in combination with the responses of 
other respondents in the final report. Data collection instruments would be kept under 
lock and key and made available to the researcher, statistician and research supervisor 
only.  
 
 Informed consent 
 
Informed consent means that respondents have adequate information regarding the 
research; are capable of comprehending the information; and have the power of free 
choice, enabling them to voluntarily consent to or decline participation in the research 
(Polit & Beck 2012:157; Brink et al 2012:38). The following aspects were included in the 
consent form for their information: the study title, purpose and objectives of the study, 
data collection method, time they would spend completing the questionnaire and the 
ways in which the findings would be used (refer to Annexure F).  
 
 
 
  
44 
 Researcher integrity  
 
The researcher has demonstrated respect for the scientific community by protecting the 
integrity of scientific knowledge. The researcher has ethical responsibilities associated 
with the conduct and reporting of the research (Brink et al 2012:43). 
 
Ethical clearance to conduct the study was obtained from the Research Ethics 
Committee of the Department of Health Studies at Unisa (refer to Annexure A). Thus, 
the study proposal was scrutinised by a Scientific Review Committee and the Ethics 
Committee. 
 
In order to preserve honesty, the researcher avoided the following activities: falsification 
of the report, manipulation of design and methods, manipulation of data and plagiarism 
(Brink et al 2012:43). The researcher reported data as it was collected. 
 
3.6 SUMMARY 
 
This chapter discussed the research design and methods used in the study. The issues 
reflected on here included population, sampling, ethical issues related to sampling, 
sample, data collection and analysis, internal and external validity of the study. 
 
Chapter 4 discusses the analysis, presentation and description of the research findings. 
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CHAPTER 4 
 
DATA PRESENTATION AND DESCRIPTION OF FINDINGS 
 
4.1 INTRODUCTION 
 
This chapter presents the analysed data and description of the findings to an evaluation 
of the Isoniazid Preventive Therapy initiation in Limpopo Province. The responses to a 
structured questionnaire, as completed by 124 respondents who met the inclusion 
criteria, were analysed and are discussed. 
 
4.2 DATA MANAGEMENT AND ANALYSIS 
 
Data analysis entails categorising, ordering, manipulating and summarising the data 
and describing them in meaningful terms (Brink et al 2012:179). Descriptive and analytic 
statistics were used to describe and synthesise the data. The researcher engaged the 
services of a statistician who analysed the data, using the Statistical Package for the 
Social Sciences (SPSS) Version 24. The analyses of data were described in detail in 
chapter three; refer to section 3.3.5. 
 
4.3 REPORT OF THE FINDINGS 
 
The findings are described below, according to sections A–E of the questionnaire. The 
information in section 4.3.1 describes the demographic profile of the respondents. 
Where applicable, this information is used in the rest of the report to relate the findings 
to specific characteristics of the respondents, for example by cross tabulation of 
information.  
 
For each of sections 4.3.2, 4.3.3, 4.3.4 and 4.3.5 a concluding summary of the main 
findings is provided. These summaries can be found in the following sections: 4.3.2.7 
Overall score per knowledge Question; 4.3.3.10 Overall IPT practice response; 4.3.4.7 
Overall resource availability and 4.3.5.12. Overall general challenges. 
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In sections 4.3.4 and 4.3.5 the description of the findings of each item is also described 
in terms of responses by the category of employment.  
 
In the discussion of the results the following will apply:   
 N: Capital letter “N” will represent the total number of respondents. 
 n:  Small letter “n” will represent the number of responses on each item. 
 %:  The sign % will represent the percentage from either “n” or “N”, where 
applicable.   
 
4.3.1 Demographic profile of the respondents (Section A) 
 
In this section the researcher determined the profile of the respondents. The 
respondents were asked to indicate their employment category, educational level, years 
of service in facility, years of experience in offering HIV/AIDS and TB services, the 
extent of training received and the type of training. The findings are reported 
accordingly. 
 
4.3.1.1 Employment category (item A4)  
 
The respondents for this study were doctors, operational managers and registered 
nurses. Figure 4.1 shows the employment category of respondents. 
 
 
Figure 4.1 Employment category 
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The larger percentage of the respondents was the registered nurses, which constituted 
70% (N=124) of the respondents. The operational managers constituted 27% (N=124) 
of the respondents and the doctors formed 3% (N=124) of the respondents.    
 
4.3.1.2 Level of education (item A1) 
 
The respondents hold different levels of education, from diploma to PhD degree (for 
certificate respondents refer to section 3.3.5). The education level of respondents is 
shown in Figure 4.2. 
 
 
Figure 4.2 Level of education 
 
Sixty percent (n=74) of respondents indicated that they possess a diploma qualification. 
The other respondents indicated that they possess either an undergraduate degree 
22% (n=28), an Honours/B Tech degree 14% (n=17), a Master’s degree 2% (n=3) or a 
PhD/Doctoral degree 1% (n=1). 
 
4.3.1.3 Years of service in facility (item A2) 
 
The respondents for this study were asked how many years they have worked in their 
specific facility. The time varied from less than one year to more than five years. The 
years of service in facility for the respondents is shown in Figure 4.3. 
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Figure 4.3 Years of service in facility 
 
The majority of respondents 67% (n=83) have worked in their facilities for more than 5 
years. The other respondents 30% (n=37) indicated that they have one to five years of 
service, 2% (n=3) have less than a year of service in their facilities and one (1) 
respondent did not indicate the length of service in the relevant facility.  
 
4.3.1.4 Years of service providing HIV/AIDS and TB services (item A3) 
 
The respondents of this study were asked how many years they had been providing 
HIV/AIDS and TB services. The time span varied from two years to 16 years and above. 
The years of service providing HIV/AIDS and TB is shown in Figure 4.4. 
 
 
Figure 4.4 Years of service providing HIV/AIDS and TB services 
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Thirty-eight percent (N=124) of respondents had been providing HIV/AIDS and TB 
services for six to 10 years. Twenty-three percent (N=124) of respondents have been 
doing it for 11 to 15 years, while another 23% (N=124) have been doing it for two to five 
years. Those who have been doing it for 16 years and above are 17% (N=124). 
 
4.3.1.5 Training on TB/HIV collaborative activities (item A5) 
 
Most of the respondents, 90% (N=124), were trained on TB/HIV collaborative activities. 
Table 4.1 illustrates the training in relation to the employment categories (item A4). 
 
Table 4.1 Training on TB/HIV collaborative activities 
 
Seventy-five percent (n=4) of doctors, 91% (n=33) of operational managers and 90% 
(n=87) of registered nurses are trained on TB/HIV collaborative activities. Opposed to 
that, 25% (n=4) of doctors, 9% (n=33) of operational managers and 10% (n=87) of 
registered nurses are not trained on TB/HIV collaborative activities.  
 
4.3.1.6 Type of training on TB/HIV collaborative activities (item A6) 
 
One hundred and eleven (n=111) respondents received training on TB/HIV collaborative 
activities in different modalities. The respondents’ type of training on TB/HIV 
collaborative activities is shown in Table 4.2. 
       Have you ever been trained on TB/HIV collaborative activities? * What is your employment 
category?  
Cross tabulation 
  
What is your employment category? Total 
Medical 
Practitioner/
Doctor 
Operational 
Manager 
Registered 
Nurse  
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No 
Count 1 3 9 13 
% within What is 
your employment 
category? 25% 9% 10% 10% 
Yes 
Count 3 30 78 111 
% within What is 
your employment 
category? 75% 91% 90% 90% 
Total 
Count 4 33 87 124 
% within What is 
your employment 
category? 100.0% 100.0% 100.0% 100.0% 
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Table 4.2 Type of training on TB/HIV collaborative activities 
 
Type of HIV/AIDS & TB training Frequency (%) 
Workshop 99 89 
From a colleague 4 4 
Job orientation 8 7 
Grand Total 111 100 
 
Eighty-nine percent (n=111) of the respondents who received training on TB/HIV 
collaborative activities attended a workshop. Four percent (n=111) received training 
from a colleague, 7% (n=111) received training through job orientation. 
 
4.3.1.7 Training on IPT initiation (item A7) 
 
The respondents for this study were asked if they had received training on IPT initiation. 
Eighty-one percent (81%, N=124) of respondents indicated that they were trained on 
IPT initiation. Table 4.3 illustrates the training on IPT initiation in relation to the 
employment categories (item A4). 
 
Table 4.3 Training on IPT initiation 
 
 
Have you ever been trained on IPT initiation?  * What is your employment category?  
Cross tabulation 
  
What is your employment category? Total 
Medical 
Practitioner/ 
Doctor 
Operational 
Manager 
Registered  
Nurse  
H
a
v
e
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o
u
 e
v
e
r 
b
e
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ra
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n
 I
P
T
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n
?
 
No 
Count 1 6 16 23 
% within What is your 
employment 
category? 25% 18% 18% 19% 
Yes 
Count 3 27 71 101 
% within What is your 
employment 
category? 75% 82% 82% 81% 
Total 
Count 4 33 87 124 
% within What is 
your employment 
category? 100% 100% 100% 100% 
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Seventy-five percent (n=4) of doctors, 82% (n=87, n=33) of operational managers and 
registered nurses, respectively received training on IPT initiation. Opposed to that, 25% 
(n=4) of doctors, 18% (n=33) of operational managers and 18% (n=87) of registered 
nurses indicated that they were not trained on IPT initiation.  
 
4.3.1.8 Type of training on IPT initiation (item A8) 
 
One hundred and one (n=101) respondents received training on IPT initiation in 
different modalities. The types of training on IPT initiation is shown in Table 4.4. 
 
Table 4.4 Type of training on IPT initiation 
 
Type of IPT initiation training Frequency (%) 
Workshop 71 70 
From a colleague 21 21 
Job orientation 9 9 
Grand total 101 100 
 
Seventy percent (n=101) of the respondents attended a workshop, 21% (n=101) 
received training from a colleague and 9% (n=101) received training through job 
orientation.  
 
4.3.2 Health care professionals` knowledge on IPT initiation (section B) 
 
The knowledge on IPT initiation questions were derived from the current South African 
National Department of Health IPT policy guidelines 2010. Respondents answered a 
total of 26 closed-ended, multiple-choice questions regarding IPT implementation. The 
questions included the following topics: exclusion of active TB, eligibility for IPT, when 
and how to start IPT, IPT and pregnancy, IPT in patients previously treated for TB and 
follow up (South Africa 2010:3–7). For the respondents to be declared knowledgeable 
on IPT initiation, s/he should have obtained 75% (19.5/26) in answering the knowledge 
questions; refer to section 3.3.4. One mark was allocated per correct answer; therefore, 
19.5 was rounded off to 20 since there were no half marks.  
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4.3.2.1 Exclusion of active TB 
 
The exclusion of TB is critical in order to avoid giving one anti-tuberculosis drug to 
patients with TB disease who require a full treatment regimen (South Africa 2010:3; 
2015a:110). The presence of TB is ruled out before IPT is initiated.  
 
In this study knowledge on exclusion of TB before IPT initiation comprised five 
questions. Respondents had to answer them to demonstrate that they were able to 
exclude TB before initiation of IPT. The five questions included these topics: 
 
 Screening a patient for specific signs and symptoms (item B1) 
 Criteria to declare a patient a TB suspect (items B2 and B10) 
 Frequency of screening HIV positive patient for TB (item B7) 
 Procedure to follow if active TB is identified (item B24) 
 
A score out of the five questions was calculated for each respondent and these 
individual scores were used to determine the mean and median score for each 
employment category 
 
Table 4.5 shows the response to knowledge on exclusion of TB per employment 
category. 
 
Table 4.5 Exclusion of TB 
 
 Exclusion of active TB score 
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What is your 
employment category? 
Medical 
Practitioner/Doctor 
4.25 4 5.00 4.00 4.00 4.50 4.00 .50 
Operational Manager 3.00 33 4.00 3.00 2.00 3.00 3.00 .50 
Registered Nurse 3.03 87 5.00 3.00 1.00 3.00 3.00 .72 
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The above table shows that operational managers’ average knowledge on exclusion of 
TB (3.00) was less than that of registered nurses (3.03). Medical practitioners had more 
knowledge on the subject, with their average knowledge score being 4.25. The median 
scores show that generally registered nurses and operational managers had the same 
knowledge. 
 
4.3.2.2 Eligibility for IPT  
 
Eligibility for IPT deals with ascertaining whether the patient qualifies for IPT or not 
based on certain aspects as stipulated by the South African National Department of 
Health IPT Policy (South Africa 2010:4; 2015a:110).   
 
In this study, knowledge on eligibility for IPT comprised of 8 questions. Respondents 
had to answer 8 questions to demonstrate that they are able to identify patient who are 
eligible for IPT before initiation. The 8 questions were as follows: 
 
 Whether TB suspect is eligible for TB (item B3) 
 Eligibility criteria (items B8, B9 and B13) 
 Exclusion criteria for IPT (items B4, B11, B12 and B26)  
 
A score out of the 8 questions was calculated for each respondent and these individual 
scores were used to determine the mean and median score for each employment 
category. Table 4.6 shows the response to knowledge on eligibility for IPT. 
 
Table 4.6 Eligibility for IPT 
 
 Eligibility for IPT 
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What is your 
employment category? 
Medical 
Practitioner/Doctor 
7.25 4 8.00 7.50 6.00 8.00 6.50 .96 
Operational 
Manager 
6.97 33 8.00 7.00 5.00 8.00 6.00 1.05 
Registered Nurse 6.92 87 8.00 7.00 3.00 8.00 6.00 1.03 
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From the above table one can deduce that medical practitioners’ knowledge on eligibility 
for IPT (mean=7.25) was more than that of operational managers (mean=6.97) who in 
turn were a bit more knowledgeable than registered nurses (mean=6.92). The median 
scores show that generally registered nurses and operational managers had the same 
knowledge. 
 
4.3.2.3 When and how to start IPT 
 
The information includes educating the patient on IPT, explaining the importance of IPT 
and adherence to treatment after commencing (South Africa 2010:6).  
 
In this study knowledge on when and how to start IPT comprised five questions. 
Respondents had to answer them to demonstrate that they know when to start IPT and 
the procedure to be followed. The five questions covered these topics: 
 
 Prerequisite for initiating IPT (item B5) 
 Information to be given to patient on IPT initiation (items B17, B18, B19 and B20) 
 
A score out of the five questions was calculated for each respondent and these 
individual scores were used to determine the mean and median scores for each 
employment category. Table 4.7 shows the responses to when and how to start IPT. 
 
Table 4.7 When and how to start IPT 
 
 When and How to start IPT 
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What is your 
employment 
category? 
Medical 
Practitioner/Doctor 
3.75 4 4.00 4.00 3.00 4.00 3.50 .50 
Operational 
Manager 
3.73 33 5.00 4.00 2.00 4.00 3.00 .84 
Registered Nurse 3.91 87 5.00 4.00 2.00 5.00 3.00 .86 
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From the above table it is clear that registered nurses’ knowledge on when and how to 
start IPT (mean=3.91) was greater than that of medical practitioners (mean=3.75) who 
in turn were a bit more knowledgeable than operational managers (mean=3.73). The 
median scores show that generally registered nurses, medical practitioners and 
operational managers have the same knowledge. 
 
4.3.2.4 IPT and pregnancy 
 
Active TB during pregnancy is associated with spontaneous abortions and adverse 
perinatal outcomes (South Africa 2010:3). Respondents’ knowledge was tested to check 
if they know how to manage an HIV positive pregnant woman.  
 
In this study knowledge on IPT and pregnancy comprised two questions. Respondents 
had to answer them to demonstrate that they know how to manage HIV positive 
pregnant women. The two questions covered the following topics: 
 
 When to start IPT during pregnancy (item B21) 
 How to manage a woman who falls pregnant while taking IPT (item B22) 
 
A score out of the two questions was calculated for each respondent and these 
individual scores were used to determine the mean and median scores for each 
employment category. Table 4.8 shows the responses to IPT and pregnancy. 
 
Table 4.8 IPT and pregnancy 
 
 IPT and Pregnancy 
M
e
a
n
 
C
o
u
n
t 
M
a
x
im
u
m
 
M
e
d
ia
n
 
M
in
im
u
m
 
P
e
rc
e
n
ti
le
 7
5
 
P
e
rc
e
n
ti
le
 2
5
 
S
ta
n
d
a
rd
 
D
e
v
ia
ti
o
n
 
What is your 
employment 
category? 
Medical 
Practitioner/Doctor 
2.00 4 2.00 2.00 2.00 2.00 2.00 .00 
Operational Manager 1.70 33 2.00 2.00 1.00 2.00 1.00 .47 
Registered Nurse 1.60 87 2.00 2.00 .00 2.00 1.00 .60 
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From the above table it is clear that medical practitioners’ knowledge on IPT and 
pregnancy (mean=2.00) was more than that of operational managers (mean =1.7) who 
in turn were a bit more knowledgeable than registered nurses (mean=1.6). The median 
scores show that generally registered nurses, medical practitioners and operational 
managers have the same knowledge.  
 
4.3.2.5  IPT in patients previously treated for TB 
 
IPT provides benefit to patients who successfully complete TB treatment. IPT can be 
started after successful completion of TB treatment or at any time after a previous 
episode of TB, provided that active TB disease is excluded (South Africa 2010:5). 
 
In this study knowledge on IPT in patients previously treated for TB comprised two 
questions. Respondents had to answer them to demonstrate that they know how to 
manage patients who were previously treated for TB. The topics were as follows: 
 
 When to start IPT in patients previously treated for TB (item B23) 
 Rationale for initiating IPT in patient previously treated for TB (item B25) 
 
A score out of the two questions was calculated for each respondent and these 
individual scores were used to determine the mean and median scores for each 
employment category. Table 4.9 shows the response to IPT in patients previously 
treated for TB. 
 
Table 4.9 IPT in patients previously treated for TB 
 
 IPT in previously treated for TB 
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What is your 
employment 
category? 
Medical 
Practitioner/Doctor 
2.00 4 2.00 2.00 2.00 2.00 2.00 .00 
Operational Manager 1.18 33 2.00 1.00 .00 2.00 .00 .85 
Registered Nurse 1.23 87 2.00 1.00 .00 2.00 1.00 .82 
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From the above it is clear that medical practitioners’ knowledge on IPT in those 
previously treated for TB (mean=2.00) was more than that of registered nurses 
(mean=1.23) who in turn are a bit more knowledgeable than operational managers 
(mean=1.18). The median scores show that generally registered nurses and operational 
managers had the same knowledge.  
 
4.3.2.6 Follow up of patients on IPT 
 
Patients who are on IPT are given a one-month supply of treatment. They are expected 
to return to the facility on a monthly basis where the health care registered will continue 
to provide on-going counselling, assessing the presence of side effects or any other 
challenges (South Africa 2010:5; 2015a:110).  
 
In this study knowledge on the follow up of patients on IPT comprised three questions. 
Respondents had to answer them to demonstrate that they are able to provide follow up 
services to patients receiving IPT. The topics covered were as follows: 
 
 IPT drug supply to patients (item B14) 
 Duration for taking IPT (item B15) 
 TB screening for patients receiving IPT (item B16) 
 
A score out of the three questions was calculated for each respondent and these 
individual scores were used to determine the mean and median scores for each 
employment category. Table 4.10 shows the responses to following up patients on IPT. 
 
Table 4.10 Follow up of patients on IPT 
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What is your 
employment 
category? 
Medical 
Practitioner/Doctor 
2.75 4 3.00 3.00 2.00 3.00 2.50 .50 
Operational Manager 2.45 33 3.00 3.00 1.00 3.00 2.00 .67 
Registered Nurse 2.37 87 3.00 2.00 .00 3.00 2.00 .67 
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From the above one can deduce that medical practitioners’ knowledge on IPT follow-up 
(mean=2.75) was more than that of operational managers (mean=2.45) who in turn 
were a bit more knowledgeable than registered nurses (mean=2.37). The median 
scores show that generally medical practitioners and operational managers had the 
same knowledge.  
 
4.3.2.7 Overall score summary per knowledge question 
 
There were 26 knowledge questions. The average knowledge score of the respondents 
was 20.12. The average knowledge score was attained by adding the scores obtained 
by the individual respondents (N=124) and dividing the total score by the number of 
respondents (N=124). Fifty percent (N=124) of respondents obtained more than 20 
correct marks out of the 26 questions, which means they obtained more than 75%. 
Twenty-five percent (N=124) of respondents obtained more than 22 correct marks 
(more than 84%). Opposed to that, 25% (N=124) of respondents obtained less than 18 
correct marks. The maximum individual score was 25 correct marks (96%) and the 
minimum individual score, which was also an outlier, was 7 correct marks (26.9%). 
Figure 4.5 shows scores per knowledge question. 
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Figure 4.5  Scores per knowledge question 
 
The most correctly answered knowledge question was “Information about TB, 
including preventive therapy, should be made available to all people living with 
HIV/AIDS” (B17) with 99.2% (n=123) of respondents answering it correctly. The most 
incorrectly answered question was the question on signs and symptoms to be 
screened prior to the initiation of IPT (B1), with only 10.5% (n=13) of respondents 
answering it correctly. Questions B 19 and B 5 almost had 50-50 splits in proportions 
of respondents getting it wrong or right. These questions were: “It is not 
recommended that IPT be initiated immediately after informing a patient of his/her HIV 
status” and “TB preventive therapy should only be offered if the following prerequisites 
can be met” respectively. Table 4.11 shows the overall knowledge score on IPT. 
  
60 
Table 4.11 Overall knowledge score on IPT 
 
 
 
The median score was 20, which means fifty percent (N=124) of the respondents 
obtained 20 correct marks and 25% of the respondents obtained 22 or more correct 
marks. The other 25% (N=124) of respondents obtained fewer than 20 correct marks. 
There was an outlier: the respondent with a score of 7. 
 
Table 4.12 Overall knowledge score 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6 Overall knowledge score  
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A closer look at the shape of the histogram of the knowledge scores show that the 
scores are normally distributed. The kurtosis of 3.018 also verifies the assumption.  
 
4.3.2.8 Overall knowledge score by educational level (item A1) 
 
The educational levels of respondents were as follows: One percent of respondents 
(N=124) reported to have a certificate (refer to section 3.3.5), 60% (N=124) of 
respondents had a diploma, 23% (N=124) had an undergraduate degree, 14% (N=124) 
of respondents had an Honours degree, 3% (N=124) of respondents had a Master’s 
degree and 1% (N=124) of respondents had a PhD degree. Most of the respondents 
were Diploma holders. Table 4.13 shows the respondents’ knowledge score by 
educational level. 
 
Table 4.13 Overall knowledge score by educational level 
 
Educational level  
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Certificate 1 22 22.00 22.00 
22.00 
 
Diploma 74 19.68 7.00 25.00 
20.00 
 
Undergraduate degree 28 21 16.00 25.00 
21.50 
 
Honours/B Tech 17 20.29 15.00 24.00 
21.00 
 
Masters 3 21 17.00 23.00 
23.00 
 
PhD/Doctorate 1 21 21.00 21.00 
21.00 
 
 
The diploma holders had the lowest average knowledge score of 19.7; however, the 
diploma respondent who reported to be a certificate holder (refer to section 3.3.5) had 
the highest average knowledge score of 22. The minimum score of 7 was from a 
diploma holder and the highest score of 25 was from the same category of diploma 
holders. The highest median score of 23 was amongst the Master’s holders and lowest 
median score of 20 was amongst diploma holders. 
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4.3.2.9 Overall knowledge score by years of service in facility 
 
Figure 4.3 shows that sixty-seven percent (N=124) of respondents worked at their 
facility for more than five years, 30% (N=124) worked from one to five years and 2% 
(N=124) worked for less than a year. One percent (N=124) of respondents did not to 
respond to the question. Table 4.14 shows the respondents’ knowledge score by years 
of service in a facility. 
 
Table 4.14 Overall knowledge score by years of service in facility 
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Non-response 1.0 21.0 21.0 21.0 21.0 21.0 21.0  
<1 Year 3.0 19.0 18.0 20.0 19.0 18.0 20.0 1.0 
1–5 Years 37.0 21.0 16.0 25.0 21.0 18.0 22.0 2.9 
>5 Years 83.0 19.8 7.0 25.0 20.0 18.0 22.0 2.9 
 
Those who worked in the facility for less than one year had the lowest average 
knowledge score of 19 as well as the lowest median knowledge score of 19. The 
maximum score of 25 was co-obtained by staff whose service in the facility was 
between one to five years and above five years respectively. There was a greater 
variance of scores within those with above five years of service, judging by the relatively 
larger standard deviation. The results seem to suggest that the more one stays in a 
facility, the more knowledgeable s/he becomes on IPT initiation. 
 
4.3.2.10 Overall knowledge score by years of service offering HIV/AIDS and TB 
services (item A3) 
 
Figure 4.4 shows that thirty-eight percent (N=124) of respondents had offered HIV/AIDS 
and TB services for six to ten years, those who had offered these services for either 11 
to 15 years or two to five years were equal in number 23% (N=124). However, the more 
experienced respondents who offered the service for 16 years and above were 17% 
(N=124).  
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Table 4.15 shows the knowledge score by years of service offering HIV/AIDS and TB 
service. 
 
Table 4.15 Overall knowledge score by year of service offering HIV/AIDS and TB 
services 
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above 
21.0 19.9 15.0 24.0 20.0 18.0 22.0 2.5 
11–15 years 28.0 20.3 7.0 25.0 20.5 18.5 23.0 3.8 
6–10 years 47.0 19.8 14.0 24.0 20.0 18.0 22.0 2.5 
2–5 years 28.0 20.7 16.0 23.0 21.0 20.0 22.0 1.9 
 
The respondents who had between six to ten years’ experience in offering HIV/AIDS 
and TB services had the lowest average knowledge score (19.8) on IPT initiation. 
Respondents with experience of between two to five years offering HIV/AIDS and TB 
services had the highest average knowledge score with the lowest variance from this 
average (standard deviation of 1.9). The median scores for all categories of experience 
offering HIV/AIDS and TB services were generally the same, between 20 and 21, 
although there was a greater variance between those in the 11–15 years of experience 
group (standard deviation of 3.8). 
 
4.3.2.11 Overall knowledge score by employment category (item A4) 
 
The researcher analysed the knowledge score by comparing the three categories of 
employment, namely doctors, operational managers and registered nurses. Table 4.16 
shows the analysis of knowledge score by employment category. 
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Table 4.16 Overall knowledge score by employment category 
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Practitioner/Doctor 
4,0 23,0 21,0 25,0 23,0 22,0 24,0 1,6 
Operational 
manager 
33,0 20,0 15,0 25,0 20,0 18,0 22,0 2,6 
Registered Nurse 87,0 20,0 7,0 25,0 20,0 18,0 22,0 2,8 
 
Medical practitioners had the highest average score of 23 on knowledge of IPT 
initiation while operational managers and registered nurses both had an average 
knowledge score of 20. The mean score of all employment categories were the same 
as the median scores. All three employment categories had one or more members 
with the highest score of 25. 
 
4.3.2.12 Overall knowledge score by training on HIV/TB collaboration activities 
(item A5)  
 
Hundred and eleven respondents (n=111) were trained on HIV/TB collaboration 
activities. The respondents’ knowledge was analysed by training on HIV/TB 
collaborative activities as shown in Table 4.17. 
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Table 4.17 Overall knowledge score by training on HIV/TB collaboration 
activities 
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Average knowledge scores on IPT initiation did not differ between those trained on 
HIV/TB collaboration although the median score for those not trained on HIV/TB 
collaboration was higher (21) than those trained on HIV/TB collaboration. However, the 
maximum score was obtained from the category of staff trained on HIV/TB 
collaboration. 
 
4.3.2.13 Overall Knowledge score by training on IPT initiation 
 
One hundred and one respondents (n=101) were trained on IPT initiation. The 
knowledge score was analysed by training on IPT initiation as shown in Table 4.18. 
 
Table 4.18 Overall knowledge score by training on IPT initiation 
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The average knowledge of IPT initiation score was marginally higher (20.2) in the 
category of staff trained on IPT initiation than those not trained on IPT initiation (20). 
However, the median knowledge scores were the same (20). The maximum score was 
amongst staff category trained on IPT initiation. Generally, nothing significant separates 
those trained on IPT from those not trained on IPT in terms of their knowledge on IPT. 
 
4.3.3 Health care professionals’ IPT initiation practice (section C) 
 
In this section the researcher determined the practice of IPT initiation at heath facilities. 
The response is categorised as strongly agree, agree, do not know, disagree and 
strongly disagree. The strongly agree response indicates the consistency in 
implementing the practice whereas strongly disagree implies non-compliance to the 
practice.  
 
4.3.3.1 Knowledge of the official policy and procedures describing IPT initiation 
(item C1) 
 
Respondents were asked if they know the policy and procedures describing IPT 
initiation. Respondents with strongly agree responses (46%; N=118) and agree 
responses (49%; N=118) were familiar with the official policy and procedures describing 
IPT initiation. Respondents with disagree responses (1%; N=118) reported that they did 
not have knowledge of the official policy and procedures describing IPT initiation. Of the 
respondents, 4% (N=118) reported ignorance or non-familiarity with the official policy 
and procedures, whereas six of the respondents did not respond to the question. Table 
4.19 shows the response to knowledge of the official policy and procedures describing 
IPT initiation. 
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Table 4.19 Knowledge of the official policy and procedures describing IPT 
initiation 
 
Response Frequency (%) 
Strongly Agree 0 0 
Disagree 1 1 
Do not Know 5 4 
Agree 58 49 
Strongly Agree 54 46 
Total 118 100 
 
A closer look at those in the strongly agree and agree response groups shows these 
responses were offered by a greater proportion of medical practitioners, Masters’ 
degree holders, those having worked in a facility for more than five years, those who 
had offered HIV/AIDS and TB services for 16 years and above, and those who had 
trained on both HIV/TB collaboration and IPT initiation. 
 
4.3.3.2 Practice of eligibility screening of all HIV positive patients for IPT (item 
C2) 
 
All respondents (N=124) agreed to the practice of screening all HIV positive patients for 
IPT eligibility. There were more strongly agree responses (72%; N=124) than agree 
responses (28%; N=124). This implies that there is a 100% chance of HIV patients 
being screened for IPT eligibility although there is an assurance probability of 72%. 
Table 4.20 shows the response to the practice of eligibility screening of all HIV positive 
patients for IPT. 
 
Table 4.20 Practice of eligibility screening of all HIV positive patients for IPT 
 
Response Frequency (%) 
Strongly Agree 89 72 
Agree 35 28 
Do not know 0 0 
Disagree 0 0 
Strongly Disagree 0 0 
Total 124 100 
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Respondents more likely to consistently (strongly agree response) screen HIV positive 
patients are medical practitioners, Masters’ degree holders, those who had served in a 
facility between one to five years, those who had offered HIV/AIDS and TB services for 
16 years and above, and those who had trained on both HIV/TB collaboration and IPT 
initiation. 
 
4.3.3.3 Provision of IPT to eligible HIV positive patients (item C3) 
 
Seventy-two percent (N=122) of respondents strongly agreed; this means that they 
were consistent in the provision of IPT to eligible HIV positive patients. The respondents 
who agreed to providing IPT to eligible HIV positive patients were 28% (N=122). This 
gives an estimated agreement in principle of 100% but a guaranteed consistency in 
issuing IPT of 72% amongst the sampled respondents. However, 2% (N=124) of 
respondents did not respond to the question. Table 4.21 shows the provision of IPT to 
eligible HIV positive patients. 
 
Table 4.21 Provision of IPT to eligible HIV positive patients 
 
Response Frequency (%) 
Strongly Agree 88 72 
Agree 34 28 
Do not know 0 0 
Disagree 0 0 
Strongly Disagree 0 0 
Total 122 100 
 
Respondents more likely to consistently provide IPT to eligible HIV positive patients 
were both medical practitioners and registered nurses, Master’s degree holders, those 
who had served in a facility between one to five years, those who had offered HIV/AIDS 
and TB services for any time period and those who had trained on both HIV/TB 
collaboration and IPT initiation. 
 
4.3.3.4 Recording of patient IPT initiations in the registers or book (item C4) 
 
One hundred and twenty-two (N=122) respondents gave answers to the question. Fifty 
percent (N=122) of respondents strongly agreed that they recorded IPT initiation in the 
facility registers or books. Both respondents who strongly agree and agreed combined 
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to make 91.8%. The respondents who strongly disagreed and disagreed combined to 
make 6.5%. This means that this latter group of respondents did not record IPT initiation 
in a register or book. The respondents who reported that they did not know whether 
they recorded IPT initiation in a register or book were 1.6%. Table 4.22 shows the 
recording of patient IPT initiation in a register or book. 
 
Table 4.22 Recording of patient IPT initiation in registers or books 
 
Response Frequency (%) 
Strongly Agree 61 50 
Agree 51 41.8 
Do not Know 2 1.6 
Disagree 7 5.7 
Strongly Disagree 1 0.8 
Total 122 100.0 
 
Respondents more likely to consistently record IPT initiations in a register or book were 
registered nurses, undergraduate degree holders, those who had served in the facility 
between one to five years, those who had offered HIV/AIDS and TB services for 11−15 
years and those trained on IPT initiation. There was no big distinction between those 
who were and were not trained on HIV/TB collaboration 
 
4.3.3.5 Recording of information on IPT initiation in the patients’ facility files 
(item C5) 
 
One hundred and twenty-three respondents gave answers to the question. Sixty-eight 
(N=123) of respondents strongly agreed and 30% (N=123) agreed to the practice of 
recording IPT initiation in the patient files. The combination of respondents who 
recorded IPT initiation information in the patients` files was 98%. However, there were 
respondents who strongly disagreed (1%; N=123) and disagreed (1%; N=123) to the 
practice. Table 4.23 shows the recording of information on IPT initiation in the patients’ 
files response. 
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Table 4.23 Recording of information on IPT initiation in the patients’ facility files 
 
Response Frequency (%) 
Strongly Disagree 1 1 
Disagree 1 1 
Do not know 0 0 
Agree 37 30 
Strongly Agree 84 68 
Total 123 100 
 
Respondents more likely to consistently record IPT initiations in a patient file were 
medical practitioners, Master’s degree holders, those who had served in the facility 
between one to five years, those who had offered HIV/AIDS and TB services for 16 
years and above, and those not trained in either HIV/TB collaboration or IPT initiation. 
 
4.3.3.6 Capturing of IPT initiated patients on a computer by a nurse or data 
capturer (item C6) 
 
Respondents were asked whether the data capturers or nurses captured all HIV positive 
patients initiated on IPT on the computer. One hundred and twenty two (N=122) 
respondents answered the question. Of those respondents, 51.6% (N=122) strongly 
agreed and 37.7% (N=122) agreed to the practice of capturing IPT initiations on a 
computer.  
 
However, 4.9% (N=122) of respondents were not sure about the capturing of IPT 
information on the computer. The respondents with strongly disagree and disagree 
answers combined to make 5.6% (N=122), meaning they reported no capturing of IPT 
initiated patients on a computer at their facilities. Table 4.24 shows the responses to 
capturing of IPT initiated patients on a computer by a nurse or data capturer. 
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Table 4.24 Capturing of IPT initiated patients on a computer by a nurse or data 
capturer 
 
Response Frequency (%) 
Strongly Disagree 2 1.6 
Disagree 5 4.0 
Do not Know 6 4.9 
Agree 46 37.7 
Strongly Agree 63 51.6 
Total 122 100.0 
 
Respondents more likely to ensure capturing of IPT initiation records in an electronic 
system were registered nurses, Master’s degree holders, those who had served in a 
facility between one to five years, those who had offered HIV/AIDS and TB services 
from 6 to 15 years and those who were not trained on HIV/TB collaboration but were 
indeed trained on IPT initiation. 
 
4.3.3.7 Follow-up of non-initiated patients (C7) 
 
The respondents were asked if they gave a follow-up date to all HIV positive patients 
who were not immediately initiated on IPT. One hundred and twenty-one (N=121) 
respondents answered the question. Of the respondents, 63.6% (N=121) strongly 
agreed and 34.7% (N=121) agreed to the practice of giving the patients a follow-up 
appointment. Only 0.8% (N=121) of the respondents strongly disagreed to the practice 
and 0.8% (N=123) reported a lack of knowledge on the practice. Table 4.25 shows the 
responses to follow-up of non-initiated patients. 
 
Table 4.25 Follow up of non-initiated patients  
 
Response Frequency (%) 
Strongly Disagree 1 0.8 
Disagree 0 0.0 
Do not Know 1 0.8 
Agree 42 34.7 
Strongly Agree 77 63.6 
Total 121 100.0 
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Respondents more likely to follow up on patients not initiated on IPT were medical 
practitioners, undergraduate degree holders, those who had served in the facility 
between one to five years, those who had offered HIV/AIDS and TB services from 11–
15 years, those who had been trained on IPT initiation, more or less regardless of 
training status on HIV/TB collaboration. 
 
4.3.3.8 IPT adherence counselling to patients (item C8) 
 
Respondents were asked if they advised the patients to adhere to IPT treatment. One 
hundred and twenty-three (N=123) respondents answered the question. All respondents 
reported that they provided adherence counselling to the patients, with 72.4% (N=123) 
strongly agreeing and 27.6% (N=123) agreeing to the practice. Table 4.26 shows the 
responses to the IPT adherence counselling. 
 
Table 4.26 IPT adherence counselling to patients 
 
Response Frequency (%) 
Strongly Agree 89 72.4 
Agree 34 27.6 
Do not Know 0 0.0 
Agree 0 0.0 
Strongly Agree 0 0.0 
Total 123 100.0 
 
Respondents more likely to offer consistent adherence counselling were the medical 
practitioners, registered nurses, Masters’ degree holders, those who had served in a 
facility between one to five years, those who had offered HIV/AIDS and TB services for 
16 years and above, and those trained on both HIV/TB collaboration and IPT initiation. 
 
The respondents were asked to explain how they advised clients to adhere to IPT 
treatment. The explanation given was that patients were taught of the benefit of IPT and 
the importance of the follow-up date; they were reminded of the importance to take 
treatment at the same time every day and to complete the course of treatment. They 
were also advised not to mix treatment with indigenous medication. 
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4.3.3.9 Monitoring and management of IPT toxicity (item C9) 
 
The respondents were asked if they always monitored and managed clients with IPT 
drug toxics. One hundred and twenty-two (N=122) respondents answered the question. 
The combination of strongly agree and agree respondents were 94.3% (n=115), with 
49.2% (n=60) strongly agreeing to the practice. Of the respondents, 0.8% (N=122) 
strongly disagreed and 2.5% (N=122) disagreed to the practice of monitoring and 
managing IPT toxicity. The other 2.5% (N=122) of respondents reported a lack of 
knowledge regarding the practice. Table 4.27 shows responses to monitoring and 
management of IPT toxicity. 
 
Table 4.27 Monitoring and management of IPT toxicity 
 
Response Frequency (%) 
Strongly Disagree 1 0.8 
Disagree 3 2.5 
Do not Know 3 2.5 
Agree 55 45.1 
Strongly Agree 60 49.2 
Total 122 100.0 
 
Respondents more likely to consistently monitor and manage the toxicity of IPT drugs 
were medical practitioners, Masters’ degree holders, those who had served in the 
facility for more than five years, those who had offered HIV/AIDS and TB services 
between 11 and 16 years and those who were not trained on HIV/TB collaboration but 
were indeed trained on IPT initiation. 
 
4.3.3.10 Overall IPT practice response 
 
Table 4.28 shows the overall IPT practice responses. 
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Table 4.28 Overall IPT practice 
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C1 
I know the official policy and procedures 
describing IPT initiation. 
54 58 5 1 0 
C2 
I screen all HIV positive patients eligible for 
IPT. 
89 35 0 0 0 
C3 I provide IPT for eligible HIV positive patients. 88 34 0 0 0 
C4 
I record all patients initiated on IPT in the 
register or book. 
61 51 2 7 1 
C5 
I record information on IPT initiation in the 
patients’ facility file. 
84 37 0 1 1 
C6 
The data capturer/nurse captures all HIV 
positive patients initiated on IPT in the 
computer. 
63 46 6 5 2 
C7 I give all HIV positive patients who were not 
immediately initiated on IPT a follow-up date. 
77 42 1 0 1 
C8 I advise clients to adhere to IPT treatment. 
89 34 0 0 0 
C9 
I always monitor and manage clients with IPT 
drug toxics. 
60 55 3 3 1 
 
The most strongly agreed with practices were “advising patients to adhere to IPT, 
screening all HIV positive patients for IPT eligibility and providing or initiating eligible 
HIV positive patients on IPT”. Recording of IPT information into the register or book 
received the least of the agreeing responses. Capturing of all HIV positive patients 
initiated on IPT by a nurse or data capturer gave the most ignored or non-compliant 
responses.  
 
4.3.4 Resource availability (section D) 
 
This section discusses the resources required for effective IPT initiation practice, 
namely a functional computer for capturing IPT initiation information, a register or book 
to record IPT initiation, TB screening questionnaires to screen HIV positive patients for 
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TB, policy guidelines on IPT initiation, shortage of the Isoniazid drug and electricity 
failure or power cuts. 
 
4.3.4.1 Availability of functional computer (item D1) 
 
Respondent were asked if there was a functional computer at their facility to capture IPT 
information. One hundred and twenty-three (N=123) respondents answered the 
question. Of the respondents, 95.9% (N=123) reported that there was functional 
computer in the facility; however, 4.1% (N=123) reported unavailability of a functional 
computer. The response to the availability of a functional computer is shown in Table 
4.29. 
 
Table 4.29 Availability of a functional computer 
 
Response Frequency (%) 
Yes 118 95,9 
No 5 4,1 
Total 123 100,0 
 
Of the respondents who reported functional computers at their facilities, 3.5% (n=118) 
were doctors, 27.1% (n=118) were operational managers and 71.2% (n=118) were 
registered nurses. Of the respondents who reported the unavailability of functional 
computers, all (n=5) were registered nurses.  
 
4.3.4.2 Availability of a register or book to record IPT (item D2)  
 
Respondents were asked if there was a register or book to record IPT initiation. One 
hundred and twenty respondents answered the question. The respondents who 
reported the availability of a register or book to record IPT initiation were 71.7% 
(N=120), whereas 28.3% (N=120) reported unavailability of a register or book to record 
IPT initiation. Table 4.30 shows the responses to the availability of a register or book to 
record IPT initiation. 
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Table 4.30 Availability of a register or book to record IPT 
 
Response Frequency (%) 
Yes 86 71.7 
No 34 28.3 
Total 120 100.0 
 
Of the respondents who reported the availability of a register or book to record IPT 
initiation, 3.5% (n=86) were doctors, 27.9% (n=86) were operational managers and 
73.3% (n=86) were registered nurses. The respondents who did not respond to the 
question were from the operational managers and registered nurses categories. 
 
4.3.4.3 Availability of TB screening questionnaires (item D3) 
 
The respondents were asked if there were TB screening questionnaires at their 
facilities. The TB screening tools assist in asking the patients questions that would 
exclude those with active TB prior to initiation of IPT. One hundred and twenty-two 
(N=122) respondents responded to the question. Of the respondents, 95.9% (N=122) 
reported the availability of TB screening questionnaires at facilities; however, 4.1% 
(N=122) reported unavailability of the questionnaires. Table 4.31 shows the responses 
to the availability of TB screening questionnaires. 
 
Table 4.31 Availability of TB screening questionnaires 
 
Response Frequency (%) 
Yes 117 95.9 
No 5 4.1 
Total 122 100.0 
 
All doctors (n=4) agreed to the availability of questionnaires. Of the respondents who 
reported availability of TB screening questionnaires, 71.8% (n=117) were registered 
nurses and 24.8% (n=117) were operational managers. Of the respondents who 
reported a lack of guidelines, 60% (n=5) were registered nurses and 40% (n=5) were 
operational managers. The respondents who did not respond to the question were an 
operational manager and a registered nurse.  
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4.3.4.4 Availability of policy guidelines on IPT (item D4) 
 
Respondents were asked if there were guidelines on IPT initiation at their facilities. The 
South African National Department of Health has developed a policy guideline for IPT 
initiation. The guideline gives directives on how to screen and manage patients who are 
eligible for IPT initiation. 
 
One hundred and twenty-two (N=122) respondents responded to the question. Of the 
respondents, 96.7% (N=122) reported the availability of IPT guidelines at their facilities. 
However, 3.3% (N=122) of respondents reported the unavailability of IPT guidelines at 
their facilities. Table 4.32 shows the responses to the availability of the policy guidelines 
on IPT. 
 
Table 4.32 Availability of policy guidelines on IPT 
 
Response Frequency (%) 
Yes 118 96.7 
No 4 3.3 
Total 122 100.0 
 
Of the respondents who reported the availability of IPT guidelines, 72% (n=118) were 
registered nurses and 24.6% (n=118) were operational managers. Of the respondents 
who reported the unavailability of IPT guidelines, 75% (n=4) were operational managers 
and 25% (n=4) were registered nurses. The respondents who did not respond to the 
question were all registered nurses.  
 
4.3.4.5 Shortage of Isoniazid medication (item D5) 
 
The respondents were asked if they had experienced shortage of the drug Isoniazid at 
the facility in the past six months. One hundred and twenty-one (N=121) respondents 
answered the question. Of the respondents, 70.2% (N=121) reported that there was no 
shortage of Isoniazid medication. However, 29.8% (N=121) of respondents reported 
that they had experienced a shortage of Isoniazid medication in the past six months. 
Table 4.33 shows the responses to the shortage of Isoniazid medication. 
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Table 4.33 Shortage of Isoniazid medication 
 
Response Frequency (%) 
Yes 36 29.8 
No 85  70.2 
Total 121 100.0 
 
All doctors (n=4) reported no shortage of Isoniazid medication. Of the respondents who 
reported no shortage of Isoniazid medication, 64.7% (n=85) were registered nurses and 
30.6% (n=85) were operational managers. Of the respondents who reported a shortage 
of Isoniazid medication, 86.1% (n=36) were registered nurses and 13.9% (n=36) were 
operational managers. Two registered nurses and one operational manager did not 
respond to the question. 
 
The respondents were given an open question to give an explanation on shortage of 
Isoniazid medication. The explanation given by those who responded was that the 
shortage had been a result of inadequate stock at the pharmaceutical depot.  
 
4.3.4.6 Electricity failure or power cuts (item D6) 
 
The respondents were asked if they had experienced electricity failure or power cuts at 
the facility in the past six months. One hundred and nineteen (N=119) respondents 
answered the question. Of the respondents, 59.7% (N=119) reported that they had 
never experienced electricity failure or power cuts. However, 40.3% (N=119) of 
respondents reported that they had experienced a power cut or electricity failure in the 
past six months. Table 4.34 shows the responses to electricity failure or power cuts. 
 
Table 4.34 Electricity failure or power cuts 
 
Response Frequency (%) 
Yes 48 40.3 
No 71 59.7 
Total 119 100.0 
 
Of the respondents who reported no electricity failure or power cuts, 63.4% (n=71) were 
registered nurses, 30.9% (n=71) were operational managers and 5.6% (n=71) were 
doctors. Of the respondents who reported electricity failure or power cuts, 20.8% (n=48) 
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were operational managers and 79.2% (n=48) were registered nurses. Five registered 
nurses did not respond to the question. 
 
The respondents were given an open question to give an explanation on electricity 
failure or power cuts. The explanation given by those who responded was that the 
power cuts they had experienced occurred during municipal maintenance, that it did not 
take the whole day and that the health facility was issued with a notice beforehand. 
 
4.3.4.7 Overall resource availability 
 
Table 4.35 shows the responses to the overall resource availability. 
 
Table 4.35 Overall resource availability 
 
  Response Yes No 
D1 A functional computer to capture IPT initiation 118 5 
D2 A register or a book to record IPT initiation 86 34 
D3 
TB screening questionnaires to screen HIV positive 
patients for TB 
117 5 
D4 Guidelines on IPT initiation 118 4 
D5 A shortage of Isoniazid medication 36 85 
D6 Electricity failure or a power cut 48 71 
 
The resources that were mostly reported to be available were: a functional computer to 
capture IPT initiation; guidelines on IPT initiation and TB screening questionnaires to 
screen HIV positive patients for TB. Some of the respondents reported electricity failure 
or a power cut and a shortage of Isoniazid medication. 
 
4.3.5 General challenges experienced by health care professionals (section E) 
 
In this section the researcher determined the challenges respondents experienced at 
facilities. The statements were formulated in a negative form and findings are reported 
accordingly.  
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4.3.5.1 Constant shortage of Isoniazid medication (item E1). 
 
The respondents were asked if they experienced a shortage of Isoniazid medication 
most of the time. One hundred and twenty (N=120) respondents answered the question. 
Of the respondents, 48.3% (N=120) strongly disagreed that there was a constant 
shortage of Isoniazid, while 35% (N=120) of respondents disagreed with the statement. 
The combination of those respondents who strongly disagreed and those who 
disagreed were 83.3% (N=120) in total. In contrast, 14.2% (N=120) of respondents 
reported constant shortage of Isoniazid medication. There were 2.5% (N=120) 
respondents who reported that they do not know whether they have experienced 
constant shortage of Isoniazid medication or not. Table 4.36 shows the responses to the 
shortage of Isoniazid medication. 
 
Table 4.36 There is always a shortage of Isoniazid medication 
 
Response Frequency (%) 
Strongly Disagree 42 35.0 
Disagree 58 48.3 
Do not Know 3 2.5 
Agree 17 14.2 
Strongly Agree 0 0.0 
Total 120 100.0 
 
Of the respondents who reported no shortage of Isoniazid medication (combination of 
strongly disagree and disagree), 69% (n=100) were registered nurses, 27% (n=100) 
operational managers and all doctors (n=4). From the respondents who reported a 
shortage of Isoniazid medication, 82.4% (n=17) were registered nurses and 17.6% 
(n=17) were operational managers.  
 
4.3.5.2 Refusal of IPT initiation by some patients (item E2) 
 
The respondents were asked if they had experienced any patients refusing IPT 
initiation. One hundred and twenty-two (N=122) respondents answered the question. 
The combination of respondents who strongly disagreed and disagreed, 94.2% 
(N=122), reported that no patients refused IPT initiation. However, 4.9% (N=122) of 
respondents reported that some patients did refuse IPT initiation (the combination of 
strongly agree and agree). Only 0.8% (N=122) of respondents reported that they did not 
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know whether some patients refused IPT initiation or not. Table 4.37 shows the 
responses to patients refusing IPT initiation. 
 
Table 4.37 Some of the patients refuse IPT initiation 
 
Response Frequency (%) 
Strongly Disagree 58 47.5 
Disagree 57 46.7 
Do not know 1 0.8 
Agree 4 3.3 
Strongly Agree 2 1.6 
Total 122 100.0 
 
Of the respondents who reported that no patient refused IPT initiation, 80% (n=115) 
were registered nurses and 16.5% (n=115) were operational managers; all respondents 
who were doctors (n=4) reported patient refusal. Of the respondents who reported that 
some patients refused IPT initiation, 66.7% (n=6) were registered nurses and 33.3% 
(n=6) were operational managers. The respondent (0.8%, N=122) who did not know 
whether or not some patients refused IPT initiation was a registered nurse. 
 
4.3.5.3 Occasional non-functional computer (item E3) 
 
The respondents were asked if they had occasionally experienced their facility’s 
computers being non-functional. One hundred and twenty-two (N=122) respondents 
answered the question. Most of the respondents (69.6%, N=122) reported that the 
facility computers were always functional (combination of strongly disagree and 
disagree responses). However, 27.8% (N=122) of respondents reported that facility 
computers were sometimes non-functional (combination of agree and strongly agree 
responses). Some respondents, 2.5% (N=122), reported that they did not know if the 
computers were sometimes non-functional. Table 4.38 shows the responses to the non-
functionality of the computers. 
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Table 4.38 The computer is sometimes not functional 
 
Response Frequency (%) 
Strongly Disagree 39 31.9 
Disagree 46 37.7 
Do not Know 3 2.5 
Agree 27 22.1 
Strongly Agree 7 5.7 
Total 122 100.0 
 
Of the respondents that reported no challenge with the functionality of computers, 
72.9% (n=85) were registered nurses and 22.4% (n=85) were operational managers. All 
respondents who were doctors (n=4) reported no challenge in this regard. Half of the 
respondents, 50% (n=34), who reported non-functional computers were operational 
managers and the other half, 50% (n=34), were registered nurses.  
 
4.3.5.4 Lack of registers or books to record IPT initiation (item E4) 
 
The respondents were asked if they had experienced a lack of registers or books in 
which to record IPT initiation. One hundred and twenty (N=120) respondents answered 
the question. Most of the respondents (71.7%, N=120) indicated that the lack of 
registers or books was not a challenge (combination of strongly disagree and disagree 
responses). There were however 27.5% (N=120) of respondents who reported that a 
lack of registers or books posed a challenge for recording IPT initiation (combination of 
strongly agree and agree responses). Table 4.39 shows the response to unavailability 
of registers or books to record IPT initiation. 
 
Table 4.39 There are no registers or books to record IPT initiation 
 
Response Frequency (%) 
Strongly Disagree 51 42.5 
Disagree 35 29.2 
Do not Know 1 0.8 
Agree 23 19.2 
Strongly Agree 10 8.3 
Total 120 100.0 
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Of the respondents who reported that a lack of registers or books to record IPT initiation 
was not a challenge, 73.2% (n=86) were registered nurses, 23.3% (n=86) were 
operational managers and 3.5% (n=86) were doctors. Of the respondents who reported 
a lack of registers or books as a challenge, 66.7% (n=33) were registered nurses, 
30.3% (n=33) were operational managers and 3% (n=33) were doctors. 
 
4.3.5.5 Lack of patients’ facility files to record IPT initiation (item E5) 
 
The respondents were asked if they had experienced a lack of patients` facility files to 
record IPT initiation. One hundred and twenty (N=120) respondents answered the 
question. Most respondents, 92.5% (N=120), reported that a lack of patients` files was 
not a challenge (combination of strongly disagree and disagree responses). There were, 
however, 6.6% (N=120) respondents who reported that a lack of patients’ files posed a 
challenge for recording IPT initiation (combination of strongly agree and agree 
responses). Table 4.40 shows the responses to the challenge of lacking patients` facility 
files for IPT recording. 
 
Table 4.40 There are no patients’ facility files to record IPT initiation 
 
Response Frequency (%) 
Strongly Disagree 67 55.8 
Disagree 44 36.7 
Do not Know 4 3.3 
Agree 7 5.8 
Strongly Agree 1 0.8 
Total 120 100.0 
 
Of the respondents who reported the lack of patients’ files as a challenge, 75% (n=8) 
were operational managers and 25% (n=8) were registered nurses. Of the respondents 
who reported that they did not know if the facility experienced the lack of patients’ files 
to record IPT as a challenge, 50% (n=4) were operational managers and the other 50% 
(n=4) were registered nurses.  
 
4.3.5.6 Postponement of IPT initiation by patients (item E6) 
 
The respondents were asked if they had experienced the postponement of IPT initiation 
by patients as a challenge. One hundred and twenty-one (N=121) respondents 
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answered the question. Most of the respondents, 85.1% (N=121), reported that they 
had no challenge with patients postponing their IPT initiation (combination of strongly 
disagree and disagree responses). There were, however, 13.2% (N=121) of 
respondents who reported that postponement of IPT initiation by patients posed a 
challenge at the facility (combination of strongly agree and agree responses). Table 
4.41 shows the responses to patients requesting time to think about IPT initiation. 
 
Table 4.41 Patients sometimes request to be given time to think about IPT 
initiation 
 
Response Frequency (%) 
Strongly Disagree 42 34.7 
Disagree 61 50.4 
Do not Know 2 1.7 
Agree 15 12.4 
Strongly Agree 1 0.8 
Total 121 100.0 
 
Of the respondents who reported that postponement of IPT initiation by patients was not 
a challenge, 73.8% (n=103) were registered nurses, 22.3% (n=103) were operational 
managers and 3.9% (n=103) were doctors. The respondents who reported that they did 
not know were all operational managers. The three respondents who did not respond to 
the question were all from the registered nurses category.  
 
4.3.5.7 Patients’ failure to return for IPT initiation (item E7)  
 
The respondents were asked if some patients ever failed to return for IPT initiation when 
given time to think about it. One hundred and twenty-one (N=121) respondents 
answered the question. Most of the respondents, 80.9% (N=121), reported that they did 
not agree with the assertion that patients never come back for IPT initiation when given 
time to think on it (combination of strongly disagree and disagree responses). However, 
15.7% (N=121) of respondents reported that patients do not come back for IPT initiation 
(combination of strongly agree and agree responses). Of the respondents, 3.3% 
(N=121) reported that they did not know. Table 4.42 shows the responses to the 
assertion that patients never come back for IPT initiation. 
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Table 4.42 Some patients, when given time to think about IPT initiation, never 
come back for initiation 
 
Response Frequency (%) 
Strongly Disagree 41 33.8 
Disagree 57 47.1 
Do not Know 4 3.3 
Agree 17 14.0 
Strongly Agree 2 1.7 
Total 121 100.0 
 
Of the respondents who reported that patients come back for IPT initiation, 78.6% 
(n=98) were registered nurses, 18.4% (n=98) were operational managers and 3.1% 
(n=98) were doctors. Of the respondents who reported that some patients do not come 
back for IPT initiation, 63.2% (n=19) were operational managers, 31.6% (n=19) were 
registered nurses and 5.3% (n=19) were doctors. Of the respondents who reported that 
they did not know, 75% (n=4) were registered nurses and 25% (n=4) were doctors. 
Those who did not respond to the question were registered nurses. 
 
4.3.5.8 Postponement of IPT initiation recording (item E8) 
 
The respondents were asked if they ever recorded IPT initiation the following day when 
they had busy days. One hundred and twenty (N=120) respondents answered the 
question. Of the respondents, 67.5% (N=120) reported that they did not record IPT 
initiation the following day (combination of strongly disagree and disagree responses). 
However, 30.8% (n=37) of respondents reported that during busy days, they did indeed 
record IPT initiation the following day (combination of strongly agree and agree 
responses). The respondents who reported that they did not know were 1.7% (N=120). 
Table 4.43 shows the responses to postponement of IPT initiation recording. 
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Table 4.43 When we have a busy day we record IPT initiation on the registers 
/books/computer the following day 
 
Response Frequency (%) 
Strongly Disagree 33 27.5 
Disagree 48 40.0 
Do not Know 2 1.7 
Agree 33 27.5 
Strongly Agree 4 3.3 
Total 120 100.0 
 
Of the respondents who reported that they did not record IPT initiation the following day, 
79% (n=81) were registered nurses, 18.5% (n=81) were operational managers and 
2.5% (n=81) were doctors. Of the respondents who reported postponement of IPT 
initiation, 54.1% (n=37) were registered nurses, 40.5% (n=37) were operational 
managers and 5.4% (n=37) were doctors.  
 
4.3.5.9 Insufficient time to screen patients for IPT (item E9) 
 
Respondents were asked if, during busy days, there was enough time to screen 
patients for IPT initiation. One hundred and twenty-one (N=121) respondents answered 
the question. Of the respondents, 49.6% (N=121) and 39.7% (N=121) reported enough 
time (combination of disagree and strongly disagree responses). There were, however, 
9% (N=121) of respondents who reported that at times there was not enough time to 
screen patients for IPT initiation (combination of strongly agree and agree responses). 
The respondents who reported that they did not know were 1.6% (N=121). Table 4.44 
shows the responses to insufficient time to screen patients for IPT. 
 
Table 4.44 During busy days there is not enough time to screen patients for 
IPT 
 
Response Frequency (%) 
Strongly Disagree 48 39.7 
Disagree 60 49.6 
Do not Know 2 1.6 
Agree 9 7.4 
Strongly Agree 2 1.6 
Total 121 100.0 
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Of the respondents who reported enough time to screen patients for IPT, 70.4% 
(n=108) were registered nurses, 25.9% (n=108) and 3.7% (n=108) were doctors. From 
the respondents who reported insufficient time 81.8% (n=11) were registered nurses 
and 18.2% (n=11) were operational managers. Of the respondents who reported that 
they did not know, one was an operational manager and one a registered nurse. Three 
registered nurses did not respond to the question. 
 
4.3.5.10 Inadequate recording of IPT due to shortage of staff (item E10)  
 
The respondents were asked if recording of IPT was ever not done properly due to 
shortage of staff. One hundred and nineteen respondents answered the question. No 
shortage of staff was reported by 76.5% (N=119) of respondents (combined strongly 
disagree and disagree responses). However, 18.5% (N=119) of respondents did report 
a shortage of staff (combined strongly agree and agree responses). Five percent 
(N=119) of respondents reported that they did not know. Table 4.45 shows the 
responses to recording of IPT not done due to shortage of staff. 
 
Table 4.45 Recording of IPT is not done properly due to shortage of staff  
 
Response Frequency (%) 
Strongly Disagree 35 29.4 
Disagree 56 47.1 
Do not Know 6 5.0 
Agree 17 14.3 
Strongly Agree 5 4.2 
Total 119 100.0 
 
From the respondents who reported no shortage of staff, 73.6% (n=91) were registered 
nurses, 22% (n=91) were operational managers and 4.4% (n=91) were doctors. From 
the respondents who reported shortage of staff 59.1% (n=22) were registered nurses 
and 40.9% (n=22) were operational managers. Of the respondents who reported that 
they did not know, 83.3% (n=6) were registered nurses and 16.7% (n=6) were doctors. 
Four registered nurses and one operational manager did not respond to the question. 
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4.3.5.11 Any other challenges or comments 
 
Respondents were given an opportunity to indicate the challenges they might have 
experienced that were not listed on the questionnaire. The findings were: poor recording 
of IPT by staff members, shortage of IPT, lack of IPT guidelines in the facility and IPT is 
initiated but not recorded.  
 
4.3.5.12 Overall general challenges 
 
Table 4.46 shows the overall responses to the general challenges  
 
Table 4.46 Overall general challenges 
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E1 
There is always shortage of Isoniazid 
medication 
0 17 3 58 42 
E2 Some of the patients refuse IPT initiation 2 4 1 57 58 
E3 The computer is sometimes not functional 7 26 3 46 40 
E4 
There are no registers or books to record IPT 
initiation 
10 23 1 35 51 
E5 
There are no patients’ facility files to record 
IPT initiation  
1 7 1 44 67 
E6 
Patients sometimes request to be given time 
to think about IPT initiation 
1 15 2 61 42 
E7 
Some patients, when given time to think about 
IPT initiation, never come back 
2 17 4 57 41 
E8 
When we have a busy day we record IPT 
initiation on the registers/books/computer the 
following day 
4 33 2 48 33 
E9 
During busy days there is not enough time to 
screen patients for IPT 
2 9 2 60 48 
E10 
Recording of IPT is not done properly due to 
shortage of staff 
5 17 6 56 35 
 
The challenges agreed on most were: “when we have a busy day, we record IPT 
initiation on the registers/books/computer the following day; the computer is sometimes 
not functional and there are no registers or books to record IPT initiation”. The 
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challenges that respondents agreed on least were: “Some of the patients refuse IPT 
initiation; there are no patients’ facility files to record IPT initiation and during busy days, 
there is not enough time to screen patients for IPT”. 
 
4.4 SUMMARY 
 
This chapter discussed the analysis, presentation and description of the research 
findings. The analysis focused on the health care professionals` knowledge on IPT 
initiation, health care professionals’ IPT initiation practice, resource availability and 
general challenges experienced by health care professionals. The statistical analysis of 
data allowed the researcher to answer the research questions and meet the objectives 
of the study. 
 
Chapter 5 presents the conclusion and recommendations for the study. 
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CHAPTER 5 
 
DISCUSSION, RECOMMENDATIONS, LIMITATIONS AND 
CONCLUSION OF THE STUDY 
 
5.1 INTRODUCTION 
 
This chapter discusses the interpretation of the research findings, contribution and 
limitation of the study, the recommendations and contribution of the study in relation to 
the research questions asked and the objectives set for the study. 
 
The study investigated the IPT initiation process amongst eligible HIV positive patients 
at health facilities in the Polokwane sub-district to identify key features in the knowledge 
and practice of health professionals as well as available resources at the health 
facilities.   
 
A quantitative, non-experimental, descriptive and cross-sectional design was adopted 
for this study. The sample for this study was all the health care professionals that work 
in the HIV/AIDS units of the Polokwane sub-district. All the operational managers, 
registered/professional nurses and doctors of the 34 public health facilities were 
requested to respond to the questionnaire. The total number of respondents was 124. 
Data was captured and analysed using the Statistical Package for the Social Sciences 
(SPSS) Version 24. Percentages, frequencies and measures or dispersion were used to 
analyse the data. 
 
5.2 DEMOGRAPHIC DETAILS OF RESPONDENTS 
 
The respondents for the study comprised doctors, operational managers and the 
registered nurses with qualifications ranging from diplomas to doctoral degrees. The 
respondents’ years of service in the facilities and their years of experience in providing 
HIV/AIDS and TB services varied from less than a year to 16 years and above. Most of 
the respondents received specific training on TB/HIV collaborative activities and IPT 
initiation, namely 75% of the doctors, 91% of operational managers and 90% of 
  
91 
registered nurses, whereas 75% of doctors and 82% of both the operational managers 
and registered nurses received training on IPT initiation. 
 
5.3 DISCUSSION OF THE RESEARCH FINDINGS 
 
The summary and the interpretation of the significant study findings are discussed in 
line with the research questions and objectives of the study. 
 
5.3.1 Health Care Professionals` knowledge on IPT initiation (section B) 
 
Observation by the researcher, of the low IPT initiation described in section 1.3 led to 
the first research question: Do the facility health care professionals (the doctors, 
operational managers and registered nurses) have knowledge on the policy and 
procedures of IPT initiation? The following section discusses the answer to that 
question and shows that the first objective of the study, which was to describe the 
knowledge of health professionals on the initiation of IPT, was met. 
 
One can assume that all the respondents have basic knowledge on TB and HIV, 
because the training and education syllabus of nurses and medical students, as 
stipulated in South African Nursing Council Training Regulation (R425) and Health 
Professions Act (Act No. 56 of 1974), include studying communicable diseases. Of 
more importance is the fact that there are specific policy guidelines to follow in practice 
in terms of the IPT initiation; refer to section 2.2. Knowledge of the IPT initiation policy 
guidelines will improve the quality of HIV and TB services that health professionals are 
offering and would eventually impact positively on the health status of the community.  
 
This study determined the respondents` knowledge of key issues of this policy 
document and the noteworthy findings are summarised below. 
 
5.3.1.1 Noteworthy knowledge questions  
 
The most correctly answered questions were on providing IPT information to patients, 
benefits of IPT and screening of patients for IPT eligibility; refer to section 4.3.2.7. They 
included:  
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 B17: Information about TB, including preventive therapy should be made 
available to all people living with HIV/AIDS (99.2%). 
 B6: IPT reduces the risk of TB infection among HIV positive patients (97.6%). 
 B7: HIV positive patients should be regularly screened for TB using a clinical 
algorithm (96.8%). 
 B10: Patients with one or more signs or symptoms are considered TB suspects 
and must be further investigated for active TB disease as per national TB 
guidelines (96.8%). 
 B20: IPT must be discussed and adequately planned to ensure full 
understanding and adherence by the patients (96.8%). 
 
This knowledge is vital in IPT initiation because it encourages patients to take informed 
actions and adhere to the IPT medication. Based on responses given to questions B17, 
B6, B7, B10 and B20 most of the respondents demonstrated more knowledge on policy 
and procedures regarding the implementation of IPT than on patient screening; this is 
similar to the findings of the study conducted by Tikuye (2013:46) in Ethiopia where the 
respondents demonstrated a high level of knowledge of the relevant policy and 
procedures for IPT initiation. 
 
However, questions on signs and symptoms suggestive of TB were those most often 
answered incorrectly; refer section 4.3.2.7. They included: 
 
 B1: Prior to the initiation of TB Prevention Therapy (IPT), a patient should be 
screened for the following signs and symptoms (89.5%). 
 B2: A TB suspect is a person with two or more of the signs and symptoms listed 
above in B1 (83.9%). 
 
Knowledge on signs and symptoms of TB is vital for IPT initiation because only eligible 
patients should be initiated. These findings suggest that there are health care 
professionals who lack information on who to do IPT initiation with, which is a crucial 
factor for IPT initiation. The findings are similar to the studies conducted by Mindachew 
et al (2014:1) in Addis Ababa and Moolphate et al (2013:60) in Northern Thailand. Both 
studies indicated a lack of health workers’ knowledge of the signs and symptoms of TB, 
which are significant for IPT initiation. 
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5.3.1.2 Overall knowledge score 
 
When the overall knowledge of respondents was analysed in terms of educational level 
and employment category, it was found that the mean and the median scores did not 
show significant differences. What is observed is the minimum score in each case. 
 
Section 4.3.2.8 shows that the lowest knowledge score was reported amongst diploma 
respondents. The scope of this study cannot explain the finding, but such a low score is 
not acceptable in terms of the expected standard of service as referred to in the ideal 
clinic manual (South Africa 2018:27). 
  
Section 4.3.2.11 shows the knowledge score per employment category. Although the 
maximum score is 25 in all three categories, the minimum score amongst the nurses of 
both categories is significantly lower than that of the medical doctors. Staffing needs are 
determined in line with Workload Indicator Staffing Needs (WISN) as indicated in the 
ideal clinic manual (South Africa 2018:248). In terms of nurses being the main category 
of professionals in health service (hospitals and clinics) in South Africa, the lack of 
knowledge shown by the low minimum scores is not ideal for the successful 
implementation of the IPT.  
 
5.3.2 Health care professionals’ IPT initiation practice (section C) 
 
Observation by the researcher of the low IPT initiation described in section 1.3 led to the 
second research question: What are the practices of IPT initiation with eligible HIV 
positive patients at the health facility? The findings in this section relied on how 
respondents rated themselves in terms of IPT practice and the integrity with which they 
completed the questionnaire. The second objective of the study, to describe the practice 
of IPT initiation at the health facilities, was met as will be seen in the following sections. 
 
5.3.2.1 Official policy and procedure for IPT initiation 
 
Most of respondents (95%) reported that they are familiar with the policy and procedure 
for IPT initiation; refer to section 4.3.3.1. The high prevalence of HIV/TB in the sub-
district of Polokwane, according to DHIS 2015/16 statistics (refer to sections 1.2 and 
2.3.2), ask for 100% knowledge of the policy and procedures by all health care 
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professionals. Each health care professional forms a link in the quest for reaching the 
90-90-90 target. The 5% of health professionals not familiar with the policy and 
procedures for IPT initiation is a weak link that cannot be afforded.  Ideal clinic manual 
(South Africa 2018:114) recommends that when new policies and notifications are 
received, the operational manager should see that the relevant staff members 
understand the changes and determine if further training may be required. 
 
5.3.2.2 The practice of screening patients for IPT eligibility 
 
In section 4.3.3.2 all respondents agreed to the practice of screening patients for IPT 
eligibility; however, this is contradicted by the mostly incorrect responses given to the 
questions on signs and symptoms suggestive of TB; refer to section 5.3.1.1. From these 
findings one can assume that screening of patients is done but that there is nonetheless 
a lack of knowledge on how to do the screening correctly. The signs and symptoms 
suggestive of TB are the determining factor for the inclusion or exclusion criteria for IPT 
initiation. Reading the policy and guidelines will promote provision of quality health 
services (South Africa 2018:114) 
 
5.3.2.3 Provision of IPT to eligible HIV positive patients  
 
In section 4.3.3.3, except for the two respondents who did not respond to the question, 
all other respondents indicated that they provided the IPT to eligible HIV positive 
patients. The specific training on HIV/TB and IPT initiation reported in section 4.3.1.5 
and 4.3.1.7 respectively seems significant to ensure consistent provision of IPT. 
 
5.3.2.4 Recording of information and data capturing 
 
Nurses are expected to record IPT initiation in the facility record and patient’s file. The 
data capturer, if available, captures the recorded information in electronic format in a 
programme provided by the government.  
 
Of the respondents, 6.5% did not make sure that recording of IPT initiation and 
treatment was done correctly in the facility registers and books; refer to section 4.3.3.4. 
If this the case, the information available to data capturers is thus incomplete and the 
data on HIV/TB that is reported at district level and then finally escalated to national 
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level is inaccurate. This has implications for future HIV/TB programmes and treatment. 
Information that is not recorded on facility records or patients’ files cannot be captured.  
Of those respondents who answered the question on the capturing of IPT information in 
the patient facility file (refer to section 4.3.3.5), 98% indicated that they recorded IPT 
initiation in the patients’ facility files. 
 
Although there are only 2% of respondents who indicated not recording IPT initiation in 
patients’ files, this again points to missing data that cannot be traced at the facilities. 
This implies that data reporting is not accurate as data that is captured in the facility 
record is sourced from patients’ files. The findings suggest that there is insufficient 
supervision by the operational managers in the clinics. 
Ideal clinic manual (South Africa 2018:110) recommends that facilities should generate 
and record accurate information for their own use and submission to district, provincial 
and national levels. 
 
5.3.2.5 Monitoring and management of IPT toxicity 
 
Most of the respondents (94.2%) indicated that they monitored and managed IPT 
toxicity; refer to section 4.3.3.9. However, other respondents (5.8%) reported not 
exercising the practice as guided by IPT guideline. The lack of monitoring and 
management of IPT toxicity implies that there are patients with medicine side effects 
who are not properly managed and this compromises quality patient care. 
 
It was found that medical practitioners were more likely to monitor and manage IPT 
toxicity than registered nurses. The operational managers should take note of this 
practice and encourage the registered nurses to implement it.  
 
5.3.3 Resource availability (section D) 
 
Observation by the researcher, of the low IPT initiation described in section 1.3 led to 
the second research question: What are the available health facility resources to initiate 
and capture IPT? The findings in this section relied on how respondents rated their 
facilities in terms of the resources required for IPT initiation and the capturing and the 
integrity with which they completed the questionnaire. The third objective of the study, to 
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describe the resources at the health facilities to initiate and capture IPT, was met as will 
be seen in the following sections. 
 
5.3.3.1 TB screening questionnaires and IPT guidelines  
 
Sections 4.3.4.3 and 4.3.4.4 show that most of the respondents reported the availability 
of screening questionnaires and IPT guidelines; however, one should also note that few 
respondents, 4.1% and 3.3% respectively, reported a lack of the resources. A lack of 
screening questionnaires can suggest that some of the patients are not screened for 
IPT, thus some eligible patients may not be on IPT. These findings show a lack of 
standardisation of service delivery in the district because the national mandates are not 
implemented the same across the country.  
 
5.3.3.2 IPT medication  
 
In section 4.3.4.5 most of the respondents indicated the availability of medication; 
however, there were a large number (29.8%) of respondents who indicated a shortage 
of medication. From these findings one can assume that there are eligible patients who 
are not initiated or maintained on IPT due to lack of medication. This is contrary to the 
maintenance of medicine minimum and maximum stock level as stipulated in the ideal 
clinic manual (South Africa 2018:56) 
  
5.3.3.3 Data capturing resources 
 
In sections 4.3.4.1 and 4.3.4.2 most of the respondents reported the availability of 
functional computers and IPT registers or books. Those who did not have functional 
computers available were 4.1%. However, there is a larger number (28.3%) of 
respondents who reported a lack of registers or books to record IPT initiation. A lack of 
registers or books suggests that clinics cannot accurately determine the patients 
initiated on IPT or those who are not initiated. This does not only affect the patients but 
also the management of the clinic in terms of ordering and use of stock. Substandard 
recording of information results in inaccurate data being reported at the sub-district, 
district, province and national levels, which result in skewed health statistics.   
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Although this was not determined in the questionnaire, the researcher realises that a 
lack of registers or books could also be due to integration of registers at primary health 
care facilities. The National Department of Health of South Africa introduced single 
comprehensive tick register, which has integrated all programmes. Some of the 
information that was in the specialised HIV/TB registers is now not available in the new 
comprehensive register.  
 
The comprehensive tick register was not singled out in the questionnaire as it forms part 
of the facility records.  
 
5.3.3.4 Electricity failure or power cut  
 
The findings in section 4.3.4.6 show that 59.7% of respondents reported no electricity 
failure or power cuts at their health facilities, while 40.3% respondents reported that 
they have indeed experienced the situation. The explanation given was that power 
failures did not occur regularly or for long periods. However, nurses and data capturers 
will have to be watchful to remember to do capturing retrospectively should a facility 
experience power failure.  
 
5.3.4 General challenges experienced by health care professionals (section E) 
 
The findings in this section relied on how respondents rated their facilities in terms of 
the challenges they experienced in IPT initiation and the integrity with which they 
completed the questionnaire. 
 
5.3.4.1 Refusal of IPT initiation by some patients 
 
In section 4.3.5.2 most of the respondents (94.2%) reported that patients did not refuse 
IPT initiation. However, 4.9% of respondents reported patients’ refusal of IPT initiation 
as a challenge. The respondents who reported refusal of IPT are two operational 
managers and four registered nurses. By strengthening the provision of appropriate 
information and counselling registered nurses can reduce the refusal rate. 
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5.3.4.2 Postponement of IPT initiation by patients 
 
The findings in section 4.3.5.6 show that 85.1% of respondents reported no 
postponement of IPT initiation by patients. There were, however, 13.2% of respondents 
who reported postponement as a challenge. Operational managers must ensure that 
patients are counselled on IPT initiation at every visit until they are undergoing initiation 
as recommended by the South African IPT policy guidelines. 
 
5.3.4.3 Patients’ failure to return for IPT initiation 
 
In section 4.3.5.7 most of the respondents (80.9%) reported having no challenge with 
patients failing to return for IPT initiation. However, 15.7% of respondents reported 
having this challenge. The failure of patients to return for IPT initiation was reported by 
respondents from all categories of employment. Strengthened counselling on the 
benefits of IPT and the effects of not undergoing IPT initiation must be given by all 
health professionals at facilities.  
 
5.3.4.4 Postponement of IPT initiation recording 
 
The findings in section 4.3.5.8 show that 67.5% of respondents record IPT initiation on 
the same day. However, 30.8% of respondents reported that during busy days IPT 
initiation was recorded the following day. Postponement of recording may lead to 
missed data capturing and inaccurate data reporting. Operational managers must 
supervise and monitor daily data capturing.  
 
5.3.4.5 Insufficient time to screen patients for IPT 
 
In section 4.3.5.9 most of the respondents (89.3%) reported having sufficient time to 
screen patients for IPT initiation. However, 9% of respondents reported having 
insufficient time to screen patients for IPT. The findings suggest that some of the eligible 
patients are missed due to the practice of not screening patients, which leads to low IPT 
initiation rate.  
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5.3.4.6 Inadequate recording of IPT due to shortage of staff 
 
The findings in section 4.3.5.10 show that 76.5% of respondents reported no shortage 
of staff whereas 18.5% of respondents reported inadequate recording due to shortage 
of staff. Inadequate recording contributes to low IPT initiation rate because of missed 
data. Operational managers must monitor the daily recording of information to ensure 
accurate data capturing and reporting. 
 
5.3.4.7 Any other challenges 
 
Section 4.3.5.11 reported on the challenge of patients being initiated on IPT but not 
being recorded. According to SANC Acts and Omissions, failure to record means an 
action was not done. Based on these findings, one can assume that IPT data is 
sometimes missed due to inadequate recording.  
 
5.4 RECOMMENDATIONS 
 
Recommendations derived from the discussion are categorised to address the practice 
at facility level as well as further research.  
 
5.4.1 Recommendations for practice 
 
The topics covered under practice recommendations include knowledge levels, 
availability of medication, record keeping and data capturing. 
 
5.4.1.1 Strategies to improve the knowledge levels of health care professionals 
 
 The policy must be available and noticeable and contain a register to be signed 
by staff to prove that they have read it. 
 New health professionals must read the policy when they first assume duty in the 
health facility and at least once every three months for which they should also 
sign a register. 
 A well planned in-service programme on the policy guidelines that actively 
involves the health professionals (nurses) responsible for the IPT initiation must 
be implemented. The SANC includes teaching as one of the roles of the nurse. 
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Registered nurses can take turns to prepare and present an in-service session 
on one of the sections of the policy. 
 The National Department of Health can develop electronic self-evaluation 
packages that health care professionals can use to monitor their knowledge on 
IPT initiation annually. Such results can be incorporated in the annual 
performance appraisal of health professionals. 
 
5.4.1.2 Availability of medication 
 
 The district pharmacist should ensure that there is proper management and 
supervision of the medicine procurement system to ensure the timeous 
procurement of medicines and to avoid interruption of service delivery of IPT.  
 The district can delegate dedicated personnel who will ensure that health care 
facilities do not run-out of medicines, e.g. Assistant Pharmacists.  
 The facility operational managers must supervise and ensure that the drug stock 
level is monitored on a weekly basis.  
 
5.4.1.3 Strategies to improve record keeping and data capturing 
 
 District HIV and TB Coordinators can present information sessions to health care 
professionals on the importance of accurate data collection and data capturing 
for planning effective health programmes. 
 Operational managers must ensure that they get feedback on the statistics from 
the sub-district. This must then be communicated to the health care professionals 
to ensure that they understand the relevance and impact of the IPT service they 
deliver.  
 Operational managers must supervise the record keeping and data capturing of 
their health care facilities. 
 The National Department of Health can also consider training of lower categories 
of registered nurses on data collection and reporting to strengthen data capturing 
practices.  
 District PHC managers must ensure the availability of equipment and stationery 
at all health facilities, such as computers, registers and screening questionnaires 
to ensure that health professionals can perform their duties. 
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5.4.2 Recommendations for further research 
 
 The quantitative findings of this study can be followed up with a qualitative 
participatory observation design. The findings of such a study will confirm the 
actual practice of IPT initiation. 
 Effective IPT initiation involves more than the knowledge and the practice of 
health care professionals. The attitude of health care professionals and the 
patients towards IPT initiation may also be explored and described. 
 Comprehensive studies should be conducted in other sub-districts, districts and 
other provinces where the national IPT initiation targets have not been met in 
order to identify possible reasons for not meeting targets. Common findings may 
assist authorities to address those issues and ensure that targets are met. 
 The research populations for future research can be defined differently so as to 
include even the data capturers to explore their knowledge and skills in ensuring 
the availability of valid and reliable IPT data reports.   
 
5.5 CONTRIBUTIONS OF THE STUDY  
 
No known scientific study has been conducted in the Polokwane sub-district to describe 
the health care professionals’ knowledge, practice and the resources available for IPT 
initiation. This study focused on more than one aspect that may impact on IPT initiation 
programme for HIV positive persons in the Polokwane sub-district, namely knowledge 
and practice of health care professionals and availability of resources.  
 
The researcher will share the study findings with the facilities, the district and the 
Provincial Department of Health through the Provincial Health Research Committee. 
This will enable the province and the district to act in terms of health care professionals’ 
knowledge and more efficient drug supply management as well as to consider the 
recommendations of the researcher 
 
The results will be uploaded to the Department of Health research data base and 
presented during the departmental research day. The researcher will present papers at 
academic conferences and report in peer reviewed professional journals. 
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5.6 LIMITATIONS OF THE STUDY 
 
The researcher included only one sub-district, namely Polokwane, where the 2014/2015 
DHIS indicated that the national target for IPT initiation was not met. The findings can 
thus not necessarily be generalised to the entire district or province. 
 
The study used structured questionnaires that were limiting to the respondents who 
wished to elaborate more on certain aspects, especially aspects related to the practice 
of IPT initiation and resource availability. 
The respondents of this study were the health care professionals involved in IPT 
initiation to eligible HIV patients. It may be that patient related factors, which are not 
included in this study, may impact on the IPT initiation. 
 
The few medical doctors (only 4) may leave the impression that they scored much 
higher than the other category. This could be countered if inferential statistics using the 
Kruskal Wallis test was used in the data analysis. 
 
5.7 CONCLUSION 
 
The findings of the study provided the researcher with evidence to determine the health 
care professionals’ knowledge, practice and resources available for IPT initiation in the 
sub-district of Polokwane. From the study findings the researcher concluded that not all 
health care professionals who are initiating eligible HIV positive patients on IPT are 
knowledgeable on IPT initiation, neither do they all provide the ideal IPT initiation 
practice. The researcher further concludes that not all health facilities have available 
resources required for IPT initiation and recording. 
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ANNEXURE F 
Informed consent by participants 
 
STUDY TITLE:  An evaluation of the Isoniazid Preventive Therapy initiation in 
Limpopo Province 
 
RESEARCHER: Khota Mmankhuma Joyce 
Masters of Public Health – University of South Africa (UNISA) 
 
I am a student at UNISA, studying towards a Master’s Degree in Public Health. I would 
like to conduct research on the initiation of IPT amongst eligible HIV positive adult 
patients, at Polokwane sub district.  
 
The study will contribute to the body of knowledge of the HIV/AIDS, STI and TB (HAST) 
directorate. The findings may be useful for the management of the Limpopo Department 
of Health and the health professionals to solve problems in the IPT initiation and thus 
contribute to meet the target for initiation set by the NDoH. 
 
The objectives of this study are to: describe the knowledge and practice of IPT initiation 
at the health facilities as well as the available resources to initiate and capture IPT.  
 
The study and its procedures have been approved by the University Of South Africa 
Department Of Health Studies Research Ethics Committee and permission was granted 
by the Limpopo Province’s Department of Health Office. 
 
As you are directly responsible for the initiation and capturing of IPT in your health 
facility, I request you to consider it to participate in the study. Your participation is 
voluntary and you have the choice of opting out of the study at any point in time, with no 
negative consequences to you or the health facility. 
 
You will have to complete a questionnaire that will take approximately 30 minutes. The 
completed questionnaires will be in confidential safekeeping and will not be available for 
any purposes other than this research. 
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Both you and your health facility will remain anonymous in this study as no names will 
appear on the questionnaires. Findings of the study will be reported in a dissertation 
and may be presented at conferences and published in professional journals.  
   
The study procedures do not involve any physical risk or harm to you or the health 
facility. Although there is no incentive for participating, you will also not face any 
financial expenses. 
 
You are free to ask the researcher or study supervisor for clarification regarding the 
study and the questionnaire. You will find contact details at the end of this document. 
 
If you consider this invitation positive I want to thank you for your time to participate and 
now request you to sign consent below. 
 
I have read this consent form, understand the content and voluntarily consent to 
participate in this study. 
 
_____________________    _______________ 
Respondent’s signature    Date 
_____________________    _______________ 
Witness (Researcher)    Date 
 
Contact details: 
Researcher: 
Mrs. Khota M.J 
Cell number: 082 674 3048. 
 
Study supervisor: 
Mrs HS du Toit 
Tel number 012 429 6305 
E-mail dtoiths@unisa.ac.za 
 
Chairperson of the University of South Africa, Department of Health Studies, Research 
Ethics Committee: 
Professor JE Maritz 
Tel number 012 429 6534 
E-mail: maritje@unisa.ac.za 
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ANNEXURE G 
Data collection tool 
 
For office use:   ID    
 
 
QUESTIONNAIRE ON IPT 
 
 
STUDY TITLE: An evaluation of the Isoniazid Preventive Therapy initiation in 
Limpopo Province 
 
RESEARCHER: Khota, Mmankhuma Joyce 
Masters of Public Health – University of South Africa (UNISA) 
 
 
 
Thank you for your willingness to participate in the research and to complete this 30 
minute questionnaire. Please complete Sections A – E. 
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SECTION A: DEMOGRAPHIC PROFILE 
 
Instructions: Please put a cross (X) in the box alongside your response. 
 
 
A1 Level of education 
 Certificate 
 Diploma 
 Undergraduate degree 
 Honours/B Tech 
 Masters 
 PhD/Doctorate 
    
 
How long have you worked 
in this facility? 
 <1year 
A2  1-5 years 
 >5 years 
    
A3 
How long have you 
provided HIV/AIDS and TB 
services? 
 0 – 1 year 
 2 – 5 years 
 6 – 10 years 
 11 – 15 years 
 16 years and above 
    
A4 
What is your employment 
category? 
 Medical Practitioner/Doctor 
 Operational Manager 
 Professional Nurse 
    
A5 
Have you ever been 
trained on TB/HIV 
collaborative activities? 
 Yes 
 No 
A6 
 
 
What was the type  
of training?                                                      
  
 
 
 
 
 
 
Workshop 
Job orientation 
By a colleague 
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A7 
Have you ever been     
trained in IPT initiation?  
 Yes 
 No 
 
             
 
A8  
 
 
 
 
SECTION B: KNOWLEDGE OF IPT INITIATION 
 
Health facilities should implement the National Department of Health’s guidelines for 
Tuberculosis Preventive Therapy among HIV infected individuals – document on IPT 
published in 2010.  
 
This above document explains, amongst other things, the screening algorithm for TB 
prophylactic therapy (PT) and the tuberculosis screening tool for adults. Its aim is to 
guide health professionals in the field of practice to implement IPT.  
 
To determine your knowledge on the content of this document, please answer all 
the following questions (1-26) to the best of your ability. Indicate your answer by 
placing an X in the applicable box: 
 
B1 Prior to the initiation of TB Prevention Therapy (IPT), a patient should be screened 
for the following signs and symptoms: 
 
A Current cough for the last 24 hours 
B Current cough for the last three weeks 
C Fever 
D Loss of weight 
E Night sweats 
F Loss of appetite 
 
What was the type of 
training?                                                      
  
 
 
 
 
 
 
 
 
Workshop 
Job orientation 
By a colleague 
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1 A C D  
2 A D E F 
3 B C D E 
4 A B C D  E 
5 A B C D E F 
 
B2 A TB suspect is a person with two or more of the signs and symptoms listed above 
in B1. 
 
1 True 
2 False 
 
B3 A TB suspect is eligible for TB Prevention Therapy (IPT): 
 
1 True 
2 False 
 
B4 Taking a history from a patient during the first visit is important and a patient can be 
found not eligible for IPT due to: 
 
A  Alcohol abuse 
B  Active liver disease  
C  Pregnancy in the case of women  
D  Having been previously treated for TB  
 
1 A B C D  
2 A C D 
3 B C D  
4 A B  
5 C D  
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B5 TB preventive therapy should only be offered if the following prerequisites can be 
met: 
 
A  High quality voluntary counselling and rapid testing for HIV is available. 
B Patients are screened for active TB disease before the initiation of TB preventive 
therapy. 
C Providers follow up and monitor patients monthly to encourage adherence, address 
side effects and exclude active TB disease. 
D The HIV/AIDS programme takes responsibility for implementing TB preventive 
therapy. 
E There is strong collaboration between HIV/AIDS and TB programmes.  
 
1 A B C D  
2 A C D 
3 B C D  
4 A B  
5 A B C D E  
 
NB: For Questions B6 to B 26, please mark one box only with an X:  
No Item 
T
ru
e
 
(2
) 
F
a
ls
e
 
(1
) 
B6 IPT reduces the risk of TB infection among HIV positive patients.   
B7 HIV positive patients should be regularly screened for TB using a 
clinical algorithm. 
  
B8 
HIV positive patients who do not have a current cough, fever, 
weight loss or night sweats are unlikely to have active TB and 
should be offered IPT. 
  
B9 Chest radiography is a requirement for screening HIV positive 
patients for IPT eligibility. 
  
B10 
Patients with 1 or more signs or symptoms are considered TB 
suspects and must be further investigated for active TB disease 
as per national TB guidelines. 
  
B11 
Patients with 1 or more signs or symptoms are not eligible for IPT 
until active TB disease has been excluded on the basis of a 
sputum smear microscopy and mycobacterial culture. 
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B12 If there is any suspicion that the patient has active TB, the patient 
should not be initiated on IPT. 
  
B13 All HIV-infected people with no signs or symptoms suggestive of 
active TB are eligible for IPT. 
  
B14 Patients starting IPT should be given a one-month supply at a 
time.  
  
B15 Patients on IPT are expected to complete the 6 months of 
therapy within a period of 9 months.  
  
B16 Patients on IPT should be screened for TB at every follow-up 
visit. 
  
B17 Information about TB, including preventive therapy, should be 
made available to all people living with HIV/AIDS.  
  
B18 
During post-test counselling following the diagnosis of HIV, the 
patient should be informed about the benefits of IPT, and should 
be invited to return to the clinic for this service. 
  
B19 It is not recommended that IPT be initiated immediately after 
informing a patient of his/her HIV status. 
  
B20 IPT must be discussed and adequately planned to ensure full 
understanding and adherence by the patients. 
  
B21 
IPT can be started at any time during pregnancy.  
 
  
B22 
IPT should be completed if a woman falls pregnant while taking 
IPT. 
  
B23 
IPT can be started after successful completion of TB treatment or 
at any time after a previous episode of TB, provided that active 
TB disease is excluded. 
  
B24 
If active TB is confirmed, patients should start TB treatment and 
receive Cotrimoxazole prophylaxis. 
  
B25 
IPT provides benefit to patients who successfully complete TB 
treatment. 
  
B26 
Patients with active liver disease or who are actively abusing 
alcohol should not be offered TB preventive therapy because of 
the risk of hepatotoxicity. 
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SECTION C: PRACTICE OF IPT INITIATION 
 
NB: Please mark one box only with an X, and, where applicable, give a brief 
description to explain your choice: 
 
 
No Item 
S
tr
o
n
g
ly
 A
g
re
e
 
(5
) 
A
g
re
e
 (
4
) 
D
o
 n
o
t 
k
n
o
w
 (
3
) 
D
is
a
g
re
e
 (
2
) 
S
tr
o
n
g
ly
 
D
is
a
g
re
e
 (
1
) 
C1 I know the official policy and procedures describing 
IPT initiation. 
     
C2 I screen all HIV positive patients eligible for IPT.      
C3 I provide IPT for eligible HIV positive patients.      
C4 I record all patients initiated on IPT in the register or 
book. 
     
C5 I record information on IPT initiation in the patients’ 
facility file. 
     
C6 The data capturer/nurse captures all HIV positive 
patients initiated on IPT in the computer. 
     
C7 I give all HIV positive patients who were not 
immediately initiated on IPT a follow-up date. 
     
C8 I advise clients to adhere to IPT treatment.      
C9 
 
 
 
 
 
I always monitor and manage client with IPT drug 
toxics. 
     
Briefly explain how (or C8): 
 _________________________________________________________________________
 _________________________________________________________________________
 _________________________________________________________________________
 _________________________________________________________________________
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SECTION D: AVAILABLE RESOURCES TO INITIATE IPT AT THE HEALTH CLINIC  
NB: Please mark one box only with an X and give a brief description to explain 
your choice where applicable (D5 and D6): 
 
No Item 
Y
e
s
 (
2
) 
N
o
 (
1
) 
My health facility has: 
D1 A functional computer to capture IPT initiation.   
D2 A register or a book to record IPT initiation.   
D3 TB screening questionnaires to screen HIV positive patients for 
TB. 
  
D4 Guidelines on IPT initiation.   
For the past six months, has your health facility ever experienced:  
D5 A shortage of Isoniazid drug/medication?   
 
Explain  
 ________________________________________________________________
 ________________________________________________________________
 ________________________________________________________________
  
D6 Electricity failure or a power cut?   
 
Explain: 
 ________________________________________________________________
 ________________________________________________________________
 ________________________________________________________________
 ________________________________________________________________
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SECTION E: GENERAL CHALLENGES 
NB: Please mark one box only with an X and give a brief description to 
explain your choice where applicable as it relates to your facility: 
 
No Item 
S
tr
o
n
g
ly
 A
g
re
e
 (
5
) 
A
g
re
e
 (
4
) 
D
o
 n
o
t 
k
n
o
w
 (
3
) 
D
is
a
g
re
e
 (
2
) 
S
tr
o
n
g
ly
 D
is
a
g
re
e
 (
1
) 
E1 There is always shortage of Isoniazid drug/medication.      
E2 Some of the patients refuse IPT initiation.      
E3 The computer is sometimes not functional.      
E4 There are no registers or books to record IPT initiation.       
E5 There are no patients` facility files to record IPT 
initiation. 
     
E6 Patients sometimes request to be given time to think 
about IPT initiation.   
     
E7 Some patients, when given time to think about IPT 
initiation, never come back for initiation. 
     
E8 When we have a busy day, we record IPT initiation on 
the registers /books/computer the following day. 
     
E9 During busy days, there is not enough time to screen 
patients for IPT. 
     
E1
0 
Recording of IPT is not done properly due to shortage of 
staff.  
     
 Any other challenges or comments: 
  
  
  
 
Thank you very much for your cooperation and for the time taken to fill in this 
questionnaire. 
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ANNEXURE H 
TB screening tool for adults 
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ANNEXURE I 
Screening algorithm for IPT 
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ANNEXURE J 
Letter from the editor 
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ANNEXURE K 
Letter from the statistician 
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ANNEXURE L 
Turnitin originality report 
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